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3-AT 3-Amino-1,2,4-triazole
α-Btx α-Bungarotoxin
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MASC muscle associated specific component
MuSK rat homologue of the muscle specific kinase (nowadays used for all species)
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NFG nerve derived growth factor
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Summary
Efficient synaptic transmission requires a high local specialization of pre- and postsynaptic 
cells. At the neuromuscular junction (NMJ), these specializations include aggregates of acetyl-
choline receptors (AChRs). Proteins of the postsynaptic apparatus implicated in the aggregation 
of AChRs include utrophin, a synapse-specific homolog of dystrophin (Ohlendieck et al., 1991; 
Bewick et al., 1992; Tinsley et al., 1992, 1994), α- and ß-dystroglycan (Ibraghimov-Beskrovnaya 
et al. 1992; Fallon and Hall, 1994), and rapsyn (Frail et al., 1988; Apel et al., 1995), thought to 
link AChRs to the cytoskeleton. Agrin, a heparansulfate proteoglycan that is synthesized by mo-
tor neurons and deposited into the synaptic basal lamina, was shown to trigger redistribution of 
AChRs to form postsynaptic aggregates (McMahan, 1990; Wallace, 1996; Ruegg and Bixby, 1998). 
It is now clear that agrin organizes postsynaptic differentiation by stimulating MuSK, a receptor 
tyrosine kinase that is expressed selectively at in skeletal muscle (Jennings et al., 1993; Valenzuela 
et al., 1995; Glass et al., 1996). Agrin and MuSK are essential for synapse formation, as mice lack-
ing agrin or MuSK fail to form neuromuscular synapses and consequently die at birth because of 
a failure to move or breathe (Gautam et al., 1996, DeChiara et al., 1996). Nevertheless, the mecha-
nisms by which agrin activates MuSK are poorly understood. Agrin stimulates the rapid tyrosine 
phosphorylation of MuSK in myotubes, but, if transiently expressed in fibroblast or myoblasts, is 
not phosphorylated by agrin (Glass et., al 1996). These data thus indicate that activation of MuSK 
depends on at least one additional component expressed in myotubes but not in myoblasts. The 
current hypothesis predicts that this component, which was termed muscle-associated specificity 
component (MASC; Glass et al., 1996), together with MuSK form an agrin receptor complex.
In this thesis, we investigated of how agrin activates MuSK and of how the signal is transmitted 
further downstream leading to the accumulation of AChRs at the synapse. In a first part, we aimed 
to identify proteins that are associated with MuSK using the membrane bound split-ubiquitin 
system, a method that is based on the yeast two-hybrid (YTH) system. In contrast to the original 
YTH system, this novel method allows to screen for proteins that pass the membrane or are as-
sociated with it. In a first step, we showed that a bait and pray both containing a constitutively 
active form of MuSK, activates the reporter genes by self dimerization indicating that this system 
is a valuable method for identifying components not intact with MuSK. Moreover, we also dem-
onstrated that the bait MuSK and a soluble form of agrin used in the YTH-screen are correctly 
expressed indicating that the system does not generate false-positive signals and can be used for 
screening. After these validation experiments, a total number of 3x107 clones were screened re-
sulting in >5’000 putative candidates. However, none of them could be could not be reconfirmed 
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in bait dependency tests. After several attempts to improve the method per se and to decrease the 
number of candidates, we were forced to drop the project as it turned out that the system had 
many intrinsic problems that could not be solved in a useful time window.
In a second project, we therefore concentrated to on mapping sites in agrin important for its 
MuSK phosphorylation and α-dystroglycan binding property. As agrin’s AChR clustering activ-
ity is mediated by the most C-terminal laminin G-like domain we concentrated on this region. 
Moreover, one particular splice variant containing an exon of 8 amino acids in length within the 
B/z splice site of the LG3 domain was shown to be the most potent isoform, whereas splice vari-
ants lacking an insert in the B/z splice site are not active at all (Gesemann et al., 1996). Guided 
by the crystal structure of the LG3 domain derived from different splice variants (Stetefeld et al., 
2004), we analyzed the contribution of single amino acids within the B/z-8 exon of agrin in ac-
tivate MuSK and show that the activity resides mostly within the side chains of a three-peptide 
motif ‘Asn-Glu-Ile’, which is also highly conserved between species. In addition, we demonstrate 
that amino acids flanking the B/z splice site also strongly contribute to agrin’s activity. Finally, we 
demonstrate that binding affinity to α-DG positively affects its MuSK phosphorylation activity. 
Based on these data we propose a model where α-DG plays an auxiliary role in capturing agrin at 
the muscle surface and thus efficiently presents the molecule to the agrin receptor complex.
In summary, the results reported in this thesis are a further step to elucidate the detailed mech-
anism of how agrin instructs the muscle to form postsynaptic structures. As similar mechanisms 
are also of work in the formation of synapses in the brain, these results are likely to be also im-
portant for furthering the understanding of how these structures are formed and altered during 
development and in process of learning and memory.
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Chapter 1
Development of the neuromuscular junction:
A general introduction
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1.1 The synapse
First described for neurons, synapses are particularly elaborate structures where information is 
processed among two cells. Synapses form the cell-cell contact between two neurons or between 
neuron and muscle. The formation of synapses requires a series of steps including the generation 
of neurons and their target cells, the guidance of axons to their targets, the formation of selective 
connections between the developing axon and its target, the differentiation of the axon’s growth 
cone into a nerve terminal, and the elaboration of a postsynaptic apparatus in the target cell. To 
ensure a precise crosstalk between the involved cells, the synapse has to be a perfect structure. It 
is a highly specialized and refined structure designed to ensure a rapid and efficient transmis-
sion of an action potential into depolarization of the postsynaptic target organ. A fast and precise 
synaptic transmission is achieved by the close spatial apposition of the presynaptic zone, contain-
ing synaptic vesicles filled with a neurotransmitter, to the postsynaptic membrane. Although the 
principles and mechanisms of synapse formation are likely to be similar in the peripheral nervous 
system (PNS) and the central nervous system (CNS), much of our understanding about the mech-
anisms of synapse formation arises from studies of the vertebrate neuromuscular synapse the 
neuromuscular junction (NMJ). The neuromuscular junction is the synapse that motor neuron 
make on skeletal muscle fibers. The advantages of the NMJ compared to a synapse between two 
neurons are striking (Fig. 1.1). Its size, its simple structure and its accessibility makes it a powerful 
system for the analysis of synaptic development.
Figure 1.1 | Comparison of neuron-neuron synapses versus neuron-muscle synapse.
(a) The postsynaptic GABAA-receptor α2 subunits (red) are clustered in dendrites of inferior olivary neurons (la-
belled with biocytin, blue) and colocalize (yellow) with the anchoring protein gephyrin (green). For details see 
(Devor et al., 2001). (b) A whole-mount view of neuromuscular synapses in rat soleus muscle. Nerve branches from 
presynaptic motor neurons and the postsynaptic muscle fibers were visualized with antibodies against laminin α2 
(red). Postsynaptic AChRs (green or yellow) accumulate at the neuromuscular junctions. Note the marked differ-
ence in synapse number and size among the tissues. Scale bar in (a) 10µm in (b) 50µm. Adapted from Bezakova et 
al., 2003.
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1.2 Development of the neuromuscular junction
The NMJ comprises portions of three cells - motor neuron, muscle fiber and Schwann cell 
(reviewed in Couteaux, 1973; Ogata, 1988; Engel, 1994; Sanes and Lichtmann, 1999) - which are 
highly specialized, containing high concentrations of organelles and molecules found at low con-
centrations extrasynaptically. They all originate from different precursor cells. Myoblast arise from 
the somite, motor axons from somata in the neural tube, and Schwann cells from the neural crest. 
During development all three cells travel long distances to meet at the synapse. Once they reach 
sites of muscles, myoblasts fuse to form myotubes, a multinucleated cell which can contain several 
hundred to several thousand nuclei. Just when or after myotubes form, they are approached by 
motor axons, followed by Schwann cells. Once the motor axon’s growth cone contacts a newly 
formed myotube, signals are exchanged between nerve and muscle that initiate the formation and 
assembly of a highly differentiated presynaptic nerve terminal and a highly specialized postsynap-
tic apparatus (Fig. 1.2 a; Dennis, 1981; Hall and Sanes, 1993; Jennings and Burden, 1993).
Figure 1.2 | Development of the neuromuscular junction.
(a) The motor axon approaches a newly formed myotube. At the area of contact, the axon differentiates into a motor nerve 
terminal that is specialized for transmitter release, Schwann cell process cap the terminal, and the muscle forms a complex 
postsynaptic apparatus. (b) Clusters of AChRs at the neuromuscular junction form. AChRs are initially present at moderate level 
throughout the muscle surface. In contrast, in adult muscle, AChRs are highly concentrated in the postsynaptic membrane and 
virtually absent extrasynaptically. This clustering involves both redistribution of acetylcholine receptors, and localized synaptic 
synthesis of AChRs. The local synthesis results from enhanced transcription of AChR genes by subsynaptic nuclei and by repres-
sion of synthesis in extrasynaptic nuclei by electrical activity. Adopted from Sanes and Lichtman, 2001.
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Muscle differentiation and synapse formation occur concomitantly during development. Func-
tional synapses form within minutes to hours after contact between developing motor nerves 
and myotubes (Fischbach, 1973; Anderson and Cohen, 1977). Over a period of about a week, 
a fully functional, albeit immature synapse forms in which both nerve and muscle are greatly 
transformed. In mammals it takes until several weeks after the first contacts are made to become 
a mature and fully differentiated synapse. The formation of a mature synapse requires further 
arborization of nerve terminals, withdrawal and editing of synaptic connections, an increase in 
the efficiency of neurotransmitter release, and additional modifications of the postsynaptic mem-
brane. The muscle fiber will ultimately be innervated by a single motor axon that terminates and 
arborizes over ~0.1% of the whole cell surface.
The postsynaptic differentiation at the NMJ is characterized by three major signaling processes 
(Sanes and Lichtman 1999, 2001; Huh and Fuhrer 2002). First, during synaptic differentiation, 
proteins initially present along the entire muscle cell surface are redistributed and concentrated 
at the site of contact with the axon of the motor neuron. One such protein is the acetylcholine 
receptor (AChR). It’s recruitment to sites of nerve-muscle contact represents a hallmark of in-
ductive events of synapse formation. An extremely high concentration of AChRs is needed at the 
postsynaptic membrane in order to ensure a rapid and reliable response to acetylcholine, the neu-
rotransmitter released from the overlying nerve terminal (reviewed in Salpeter and Loring, 1985). 
Initially the AChR receptors have a uniform density of ~1000/µm2 over the whole plasma mem-
brane (Bevan and Steinbach, 1977; Merlie, 1984). In mature muscle the density of AChRs reaches 
>10’000/µm2 synaptically and falls to ~10/µm2 extrasynaptically (Fig. 1.2 b; Salpeter et al., 1988). 
Second, the differential distribution of synaptic proteins, including AChRs, is enhanced by selec-
tive transcription of genes encoding these proteins from only those nuclei underneath the nerve 
terminal (Fig. 1.2 b). Third, transcription of RNAs from extrasynaptic nuclei is downregulated in 
response to depolarization of the myotubes caused by AChR activation. While downregulation of 
protein synthesis is clearly driven by electrical activity (Goldman et al., 1988; reviewed in Duclert 
and Changeux, 1995), aggregation of proteins at the nerve-muscle contact depends on instructive 
signals that are released by the motor axon.
In a pivotal series of experiments begun in the late 70s, U.J. McMahan and colleagues demon-
strated that molecules stably associated with the synaptic portion of the myofiber’s basal lamina 
sheath trigger the formation of presynaptic and postsynaptic specializations in regenerating nerve 
and muscle fibers. In these experiments, axons of motoneurons and myotubes were destroyed and 
only the basal membrane was left intact. When presynaptic and postsynaptic cells were allowed to 
regenerate they formed synapses at the same position where they originally were located (Sanes et 
al., 1978; Burden et al., 1979). 
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Following the demonstration that neurites organize AChR clusters at sites of nerve-muscle 
contact (Anderson and Cohen, 1977; Frank and Fischbach, 1979), and that basal lamina asso-
ciated molecules assume instructive properties, several groups used cultured myotubes to seek 
clustering agents. Typically, a fluorescent derivative of α-bungarotoxin (α-Btx), a very specific 
quasi-irreversible ligand, was used to assay AChR distribution in vivo and on myotubes in culture 
(Lee, Tseng, and Chin, 1967). Proteins of the basal lamina were tested on their activity on cultured 
myotubes. It turned out that molecules that are active in this assay include fibroblast growth fac-
tor (Peng et al., 1991), HB-GAM/pleiotropin (Peng et al., 1995; Rauvala and Peng 1997), laminin 
(Sugiyama et al., 1997; Montanaro et al. 1998), midkine (Zhou et al., 1997), and agrin. Of these 
only agrin has so far been implicated in synaptogenesis in vivo.
Based on the biological activity of agrin and its tissue distribution McMahan postulated in 
1990 the ‘agrin hypothesis’ where he proposed that agrin is the nerve derived trophic factor that is 
responsible for the differentiation and assembly of the postsynaptic apparatus in vivo. Thereafter, 
it was demonstrated that agrin is synthesized by motoneurons, transported down motor axons, 
and released from motor nerve terminals, and incorporated into basal lamina of the synaptic cleft 
(McMahan, 1990; Reist et al., 1992; Cohen and Godfrey, 1992).
1.3 Agrin
Agrin – from the Greek ‘agrein’ meaning ‘to assemble’ which was named after its ability to 
aggregate AChRs - was purified by McMahan and colleagues using basal lamina extracts from 
electric organ of the pacific electric ray Torpedo californica, which is a plentiful source of NMJ-like 
synaptic components (Godfrey et al., 1984; Nitkin at al., 1987). Agrin was then molecularly cloned 
from mammals and birds (Rupp et al., 1991, Tsim et al. 1992). In all of the species from which 
agrin was cloned, the gene encodes a protein of more than 2’000 amino acids with a predicted 
mass of 225 kDa. The extensive N- and O-glycosylation of the amino terminal half increases the 
apparent molecular mass of agrin to 400-600 kDa. At least three of the O-linked carbohydrate at-
tachment sites function as docking sites for heparan sulfate glycosaminoglycan (HS-GAG) side 
chains and assign agrin to the family of heparan sulfate proteoglycans (Fig. 1.3; Tsen et al., 1995; 
Denzer et al., 1998). These heparan sulfate chains are clearly important for mediating the binding 
of some other molecules. Fibroblast growth factor 2 (FGF2), thrombospondin, and neural cell 
adhesion molecule (NCAM) can bind agrin via heparan sulfate chains (Cole and Halfter, 1996; 
Cotman et al., 1999). In addition, laminin-1 and laminin-2 bind agrin in part via heparan sulfate 
chains (Cotman et al., 1999). Agrin can undergo extensive alternative messenger RNA splicing, 
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which gives rise to proteins, which differ in function and localization. Alternative splicing gives 
rise to two agrin isoforms with different amino terminus. One isoform encodes a cleaved signal 
sequence (SS) followed by the amino (N)-terminal-agrin (NtA) domain (Fig. 1.3). This form of 
agrin (SS-NtA-agrin) is expressed in both neural and non neural tissue, appears to account for 
most of the agrin in motoneurons and muscle, and is efficiently secreted and incorporated into 
the basal lamina (Denzer et al., 1995; Burgess et al., 2000). The other isoform encodes a shorter 
amino terminus with an internal, non-cleaved signal peptide, which converts the protein to a type 
II transmembrane (TM) protein (Burgess et al., 2000; Neumann et al., 2001). This splicing affects 
the association of agrin with the ECM, as only the SS-NtA-agrin isoform can bind to laminins 
(Denzer el al., 1995, 1997; Mascarenhas et al. 2003). In contrast TM-agrin is mostly found in 
the brain, which does not contain any basal lamina. The laminin binding or the transmembrane 
domain are followed by nine follistatin-like (FS) modules, two laminin EGF-like (LE) repeats, 
two serine/threonine (S/T) rich regions and a sea urchin sperm like module (SEA) (Fig. 1.3). The 
carboxy (C)-terminal half of agrin, containing 4 EGF-like (EG) and 3 laminin G-like (LG) mod-
ules, encodes the fragment that was originally purified by McMahan and colleagues (Nikitin at al., 
1987), and is sufficient to induce AChR clustering on cultured muscle cells. This carboxy terminal 
part that is common to both, the SS-NtA and the TM-agrin isoforms, is subjected to alternative 
splicing (Fig. 1.3). These splice sites are known as A/y in LG2 domain and B/z in LG3 domain, 
where A and B is used to denote these sites in avians (Ruegg et al., 1992) and y and z in mammals 
(Ferns et al 1992). The A/y site contains a highly positively charged 4 amino acid insert (KSRK) 
which is essential for the binding of the inhibitor heparin to agrin, but does not affect the cluster-
ing activity of the neuron-specific isoforms of agrin (Hopf and Hoch, 1997; Gesemann et al., 1996; 
Campanelli et al., 1996). The best characterized splice region in the C-terminus of agrin is the B/z 
site, which is encoded by two exons of 24-bp and 33-bp in length. Thus, the protein either lacks 
the corresponding amino acids or contain 8, 11 or 19 (8+11) amino acid-long inserts (Tsim et al., 
1992; Hoch et al., 1993; Wei et al., 1997). AChR aggregation assays on cultured myotubes showed 
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Figure 1.3 | Schematic representation of full length chick agrin. 
Cartoon showing the structural domains of agrin, the sites of alternative messenger RNA splicing and the glycosylation sites. SS, signal sequence; 
NtA, amino terminal agrin domain; TM, transmembrane segment; FS, follistatin-like domain; LE, laminin EGF-like domain; S/T, serine/threonine 
rich region; SEA, sperm protein, enterokinase and agrin domain; EG, epidermal growth factor domain; LG, laminin globular like domain.
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that only those splice variants containing amino acid inserts, at splice site B/z collectively called 
neural agrin, induce the clustering of AChR, while the variants lacking inserts, also called muscle 
agrin, was inactive (Ruegg et al., 1992; Ferns et al., 1993). 
Three lines of evidence indicate that agrin is necessary for the clustering of AChRs at synaptic 
sites and for inducing postsynaptic differentiation. First, antibodies against agrin block AChR 
clustering at nerve-muscle synapses that form in culture (Reist et al., 1992). Second, agrin defi-
cient mice lack differentiated NMJs including clusters of AChRs and of other postsynaptic mark-
ers (Gautam et al., 1996). Agrin also regulates the distribution of other synaptic proteins, includ-
ing neuregulin (NRG), and NRG receptors (ErbBs), indicating that agrin has a central role in 
synaptic differentiation (McMahan, 1990; Apel et al., 1995; Rimer et al. 1998; Meier et al., 1997). 
Third, in a gain of function experiment, agrin complementary cDNA or recombinant agrin was 
microinjected ectopically into myofibers or into the muscle respectively in vivo. In the case of 
neural, but not muscle agrin isoforms, the injection causes the formation of ectopic postsynaptic 
specializations that contain clustered AChRs in association with many other postsynaptic pro-
teins, deep membrane folds and adult type AChRs (Bezakova et al., 2001; Cohen et al., 1997; Meier 
et al., 1997; Jones et al., 1997; Rimer et al., 1997, 1998).
1.4 The agrin receptor
In efforts to understand how agrin acts, a number of proteins have been identified that in-
teract with agrin via different domains. The N-terminal region of agrin interacts with laminins, 
tenascin, FGF-2, NCAM, HB-GAM/pleiotrophin, thrombospondin and ß-amyloid; whereas the 
C-terminal region associates with α-dystroglycan, heparin/heparan sulfates, and integrin (Bowe 
et al., 1994; Campanelli et al., 1994, 1996; Gee et al., 1994; Sugiyama et al., 1994; Martin and Sanes, 
1995, 1997; Mook-Jung and Gordon, 1995; Storms et al, 1996; Dagget et al., 1996; Gesemann et 
al., 1996; O’Toole et al., 1996; Hopf and Hoch, 1996; Denzer et al., 1997; Zhou et al., 1997; Cotman 
et al., 1999,2000). Since the C-terminal region of agrin is sufficient to induce AChR clusters on 
cultured myotubes, all proteins which bind to the amino-terminus of agrin were excluded. Of all 
the other proteins, only α-dystroglycan was initially proposed as a functional agrin receptor that 
mediates downstream signaling leading to AChR aggregation (Bowe et al., 1994; Gee et al., 1994; 
Campanelli et al., 1994; Sugiyma et al., 1994).
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1.4.1 α-dystroglycan
Dystroglycan is transcribed from a single gene and is post-translationally modified to yield 
two glycoproteins, namely α- and ß-dystroglycan. The N-terminal peripheral membrane pro-
tein α-dystroglycan (α-DG) links to the extracellular matrix via several ligands, whereas the 
transmembrane ß-dystroglycan (ß-DG) links α-DG by a tight but non-covalent link to the actin 
cytoskeleton via dystrophin (Ervasti and Campbell, 1991) or utrophin (Matsumura et al., 1992). 
The idea that α-DG could be the functional agrin receptor was supported by the fact that α-DG is 
a major binding protein for agrin and can bind agrin with high affinity. Moreover, agrin’s bind-
ing to α-DG is Ca2+-dependent as is the formation of AChRs and the binding can be inhibited 
by heparin. Furthermore antibodies against α-dystroglycan have been reported to perturb the 
formation of AChR clusters induced by agrin (Campanelli et al., 1994; Gee et al 1994). Contrarily, 
others have reported contemporarily the same antibodies to be ineffective in altering the response 
to agrin (Sugiyama et al., 1994). It was also shown that α-DG can also bind the ‘inactive‘ agrin-B/
z- with high affinity (Gesemann et al., 1996; Hopf and Hoch, 1996; Sugiyama et al., 1994), but this 
form of agrin neither stimulates nor antagonizes AChR clustering by active, neural agrin (Hoch 
et al., 1994). In addition dystroglycan-binding sequences in agrin are not necessary for AChR 
clustering (Gesemann et al., 1995). Conversely, LG3-B/z+, the minimal agrin fragment that can 
aggregate AChRs, does not bind to α-DG at all (Gesemann et al., 1996). Therefore, α-DG might 
be involved in the consolidation of postsynaptic structures but seems not to be involved in their 
formation, as it does not fulfill the criteria for a signaling receptor.
1.4.2 MuSK
Several groups provided contemporarily strong evidence for the involvement of another pro-
tein as putative agrin receptor, the muscle-specific transmembrane receptor tyrosine kinase, 
MuSK (Jennings et al., 1993; Ganju et al., 1995, Valenzuela et al., 1995).
MuSK was originally identified in an unrelated search for signaling molecules in muscle after 
denervation (Valenzuela et al., 1995). Its orthologue was also cloned from the electric organ of 
Torpedo (Jennings et al., 1993). At the adult NMJ, MuSK is concentrated at the postsynaptic site 
(Valenzuela et al., 1995; Ganju et al., 1995). Its extracellular domain (ECD) contains three IgG-
like domains and 5 potential N-linked glycosylation sites, some of which are glycosylated (Fig. 1.4; 
Watty et al., 2002). Alternative mRNA splicing gives rise to several isoforms of MuSK that differ 
at two splice sites within the extracellular domain (Fig. 1.4; Valenzuela et al., 1995; Ganju et al., 
1995; Hesser et al., 1999). Moreover, a Wnt-receptor cysteine-rich domain (CRD), defined by a 
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pattern of ten cysteine residues, was found in the ECD of MuSK (Fig. 1.4; Saldanha et al., 1998, 
Masiakowski and Yancopoulos, 1998). The CRD was suggested to act as binding site for Wnt 
proteins (Bhanot et al., 1996), but so far nothing is known about the biological function of this 
CRD. Intracellularly, MuSK contains a juxtamembrane (Herbst et al., 2000) domain followed by 
a kinase domain and a short C-terminal tail, which confers a PDZ binding domain (Zhou et al., 
1999).
MuSK emerged as the best candidate agrin receptor since there are many data implicating that 
agrin acts as ligand for MuSK, but it turned out that MuSK alone is not sufficient. Gene targeting 
experiments were done to examine the role of MuSK in NMJ development. MuSK-deficient mice 
lack any pre- and postsynaptic specializations and die perinatally (Fig 1.5; DeChiara et al., 1996), 
as do agrin-deficient mice (Fig 1.5; Gautam et al., 1996). Cultured myotubes devoid of MuSK are 
not capable of aggregating AChRs in response to neural agrin, and the ability of myotubes to form 
AChR clusters recovers after MuSK expression is restored (Herbst et al., 2002). Agrin B/z+, but not 
agrin B/z-, induces MuSK phosphorylation and, as observed for AChR aggregation, the minimal 
active fragment comprises the LG3-B/z+ domain (Gesemann et al., 1996). In cultured myotubes, 
agrin can be chemically crosslinked with MuSK, but agrin cannot activate MuSK expressed in 
myoblast or other undifferentiated cells (Glass et al., 1996). Based on this observation, it has been 
proposed that MuSK needs to associate with a myotube-associated specificity component, termed 
MASC, in order to constitute a fully functional receptor that both binds and responds to agrin 
(Glass et al., 1996). Despite substantial effort, the nature of MASC has remained largely elusive so 
far. It remains possible that a co-ligand or post translational modifications of MuSK, rather than 
a coreceptor, is required for agrin to stimulate MuSK.
Ig1 Ig2 Ig3 CRD JXTD kinase domain
A0 : ............................................
A10 : ......................EDREPEQDAK
A20 : ALNMTNATEREDREPEQDAK
B0 : ................
B8 : DYKKENIT
Figure 1.4 | Schematic representation of the muscle specific kinase. 
Schematic drawing of MuSK showing its structural domains, the sites of alternative mRNA splicing and putative N-glycosylation 
sites. Ig, immunoglobulin-like domain; CRD, cysteine rich domain; JXTD, domain.
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1.5 Mechanisms activated by agrin that lead to AChR 
clustering
Another important question is of how activated MuSK transmits a signal into the myotubes to 
induce organization of the postsynapse. Early experiments showed that a 43-kD protein, termed 
rapsyn, has an important role in agrin-mediated signaling. Rapsyn, originally identified as AChR-
associated protein in Torpedo synaptic membranes (Sobel et al., 1978, Burden et al., 1983, Porter 
et al., 1983), is an amphiphatic, myristoylated peripheral membrane protein that is present at 1:1 
stoichiometry with AChRs at synaptic site (Burden at al., 1983; Froehner et al., 1991; Phillips and 
Merlie, 1992).
Like the agrin and the MuSK knockouts, rapsyn-deficient mice have perturbed NMJs, and 
the animals die at birth due to failure to breathe. Presynaptic specializations still form, although 
the motor terminals arborize poorly and grow more extensively than in wild-type mice (Fig 1.5; 
Gautam et al., 1995). Importantly, normal clustering of AChRs, neuregulin receptors, utrophin 
and dystroglycan is lacking in rapsyn mutant mice (Gautam et al., 1995).
MuSK is the only postsynaptic protein to still be localized synaptically at mutant NMJs in rapsyn-
deficient mice. In cultured myotubes from rapsyn mutant mice, neural agrin still induces rapid 
phosphorylation of MuSK, but the AChR ß-subunit does not become tyrosine phosphorylated. 
Likewise, myotubes cultured from these mutant mice do not form AChR clusters spontaneously 
nor in response to agrin, showing that rapsyn acts downstream of MuSK (Apel et al., 1997). This 
suggests that rapsyn serves as an adaptor molecule to link MuSK activation to further downstream 
events that are important for localization of molecules to the postsynaptic apparatus, like AChRs 
for instance.
These findings still leave the question open of how MuSK transduces the signal, follow-
ing stimulation by agrin, further downstream. In response to agrin, MuSK undergoes rapid 
autophosphorylation, a response which occurs within minutes and precedes all putative down-
stream signaling events and AChR clustering (Glass et al., 1996). MuSK is phosphorylated on six 
of the nineteen cytoplasmic tyrosine residues (Watty et al., 2000). Such phosphorylated tyrosines 
could then act as docking sites for the binding of signal-transducing molecules, in analogy to 
many other RTKs. Several of MuSK’s cytoplasmic tyrosine residues are indeed essential for AChR 
clustering in response to agrin in myotubes, as shown by mutational analysis of MuSK and 
transfection into MuSK-/- myotubes (Herbst and Burden, 2000; Zhou et al., 1999). In particular 
the juxtamembrane tyrosine (Y553) appears to be required for agrin-induced AChR clustering 
(Zhou et al., 1999; Herbst and Burden, 2000). The amino acid sequence surrounding Y553 fits a 
typical NPXY motif which is believed to interact with a phosphotyrosine binding (PTB) domain-
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containing protein as it is the case for Shc and related proteins. However, the protein that binds to 
the NPXY motif remains to be identified.
Because MuSK is absolutely essential for the pre- and postsynaptic differentiation at the NMJ, 
extensive efforts have been invested to understand of how MuSK transduces the signal. Using the 
intracellular region of MuSK as bait, Dishevelled (Dvl) was identified as a MuSK binding protein. 
Dvl was originally discovered in Drosophila for its role in the development of coherent arrays of 
polarized cells (Perrimon and Mahowald, 1987). Dishevelled 1 is enriched at the NMJ (Luo et al., 
2003) and inhibition of Dvl function or expression, which has no effect on AChR expression in 
muscle cells, attenuates agrin-induced AChR clusters and the formation of the neuromuscular 
synapse in culture (Luo et al., 2002). Interestingly, MuSK shares a conserved extracellular CRD 
domain with the Wnt receptor Frizzled (Dann et al., 2001; Masiakowski and Yancopoulos, 1998; 
Xu and Nusse, 1998). The finding that Dvl regulates agrin-induced AChR led to determine wheth-
er the Wnt signaling pathways are involved in this event: the canonical pathway and the planar 
cell polarity pathway involving activation of Rho GTPases (Habas at al., 2001). The finding that 
Dvl interacts with MuSK suggests that one or both pathways of Wnt may be involved in regulating 
or mediating AChR clustering. Indeed, it was shown that agrin stimulates Cdc42 and Rac, both of 
which are required for AChR clusters (Weston et al., 2000, 2003). Moreover, PAK is activated by 
agrin and is required for AChR clusters (Luo et al., 2002). Importantly, agrin-induced PAK acti-
vation is attenuated in muscle cell is expressing mutant Dvl, suggesting the involvement of Dvl in 
this event. However, the underlying mechanisms of the Dvl participation remain unclear.
Beside MuSK, agrin stimulates also tyrosine phosphorylation of AChRs ß- and ∂-subunits 
(Ferns et al., 1996; Fuhrer and Hall, 1996; Qu and Huganir, 1994; Wallace et al., 1991). However, 
the function of AChR tyrosine phosphorylation is not well understood. It was shown that it is in-
sufficient to cluster AChRs, as AChR tyrosine phosphorylation but not AChR clustering is stimu-
lated in muscle cells that are transfected with TrkC/MuSK chimera and treated with NT3 (Glass 
et al., 1997). Therefore, tyrosine phosphorylation of AChRs could regulate AChR clustering by 
initiating a link between AChRs and the cytoskeleton (Wallace, 1992). Consistent with this idea, 
a phosphotyrosine (Y393) -containing sequence in the ∂-subunit serves as docking site for Grb2 
(Colledge and Froehner, 1997), raising the possibility that Grb2 serves as adaptor to link tyrosine 
phosphorylated ∂-subunits to additional proteins, possibly a cytoskeletal complex.
Moreover, the kinase that phosphorylates AChR appears to be distinct from MuSK (Ferns et 
al., 1996; Fuhrer et al., 1997; Wallace et al., 1994). Indeed, agrin causes rapid activation of Src-re-
lated kinases (Mittaud et al., 2001), but addition of staurosporine blocks agrin-stimulated tyrosine 
phosphorylation of AChRs without inhibiting tyrosine phosphorylation of MuSK, indicating that 
tyrosine kinases other than MuSK catalyze AChR tyrosine phosphorylation (Swope and Huganir, 
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1993; Ferns et al. 1996; Fuhrer and Hall, 1996; Fuhrer, 1999). Furthermore, agrin stimulates ty-
rosine phosphorylation and clustering of AChRs in mutant muscle cells lacking either Src and 
Fyn or Src and Yes and in muscle cells treated with inhibitors for Src-family kinases (Smith et al., 
2001, Mohamed et al., 2001). Thus kinases other than Src-family kinases appear to catalyze AChR 
tyrosine phosphorylation and clustering.
While these studies begin to piece together signaling pathways that lead to AChR clustering, 
the exact pathway from MuSK to downstream molecules remains unclear.
Figure 1.5 | Genetic analysis of early AChR clustering events in mice deficient for MuSK, agrin or rapsyn.
In newly innervated wild-type muscles (embryonic day (E) 14), some axons terminate on AChR-poor parts of the myotube surface and 
some AChR clusters are unoccupied by nerves. By E15 (E18 is shown here), the apposition of pre- and postsynaptic specializations is mark-
edly improved. AChR clusters form normally in mutant lacking B/z+ agrin or all forms of agrin. Later, clusters become smaller, dimmer and 
fewer in agrin mutants. No AChR clusters form in mice lacking muscle-specific kinase or rapsyn, but localized AChR transcription persists 
(yellow region) in the absence of rapsyn. Adapted from Sanes and Lichtman, 2001.
Wild type
Agrin-/-
MuSK-/-
Rapsyn-/-
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1.6 Glycosylation at the synapse
Differential glycosylation of MuSK and other synaptic molecules could be an alternative way 
to explain the difficulty in identifying MASC. The possibility that cellular interactions within the 
vertebrate nervous system are mediated by cell surface carbohydrates has been considered on nu-
merous occasions. The initial suggestions that carbohydrate structures might mediate neural cell 
adhesion were based on the expression of complex oligosaccharides, in particular gangliosides, 
by neural cells, and the detection of cell surface glycosyltransferases that were proposed to func-
tion non-enzymatically as receptors for cell surface oligosaccharides (Roseman, 1970; Roth et al., 
1971; Marchase, 1977; Suhr and Roth, 1975). Subsequent progress in elucidating the function 
of cell surface carbohydrates in the nervous system has, however, been slow, in part because of 
the difficulties (i) in purifying and characterizing complex oligosaccharides that are expressed 
on small subsets of neural cells and (ii) in generating these structures synthetically. In addition, 
the identification of cell surface molecules such as NCAM, N-cadherin, and integrins (Edelman, 
1986a, 1986b; Takeichi, 1988; Ruoslathi and Pierschbacher, 1987; Rutishauser and Jessel, 1988) 
has focused attention on mechanisms of neural cell adhesion that involve direct protein-protein 
interactions.
While it is clear that protein-protein associations are important for the aggregation of molecu-
lar complexes at the neuromuscular synapse, the role of carbohydrates in this process is largely 
unknown. Given that very high concentrations of carbohydrates are present at synapses, it is likely 
that their structure contributes to the organization of synaptic molecules. In fact, most of the 
molecules found in the extracellular matrix, which are important during development, regenera-
tion and synaptic plasticity, are highly glycosylated with carbohydrate structures. Moreover, it 
was shown that synaptic molecules of the NMJ have unique carbohydrate structures with respect 
to the extrasynaptic membrane (Martin and Sanes, 1995; Martin et al., 1999). Therefore, carbo-
hydrates have probably more than just a passive role at the synapse, they may also affect synaptic 
adhesion, signaling, and transmission (Martin, 2002).
Given that many different carbohydrate structures can be synthesized by a single cell, the po-
tential complexity of carbohydrate structures, on a molecule per molecule basis, exceeds that of 
proteins. For example, combining the eight common mammalian carbohydrates into a chain sev-
en carbohydrates long in all possible configurations and forms would yield a number of structures 
that exceeds the number of neurons in the brain. The tremendous structural diversity of glycan 
chains allows for immense combinatorial possibilities that might underlie the fine-tuning of cell-
cell and cell-matrix interactions as well as signaling processes (reviewed in Martin, 2003; Kleene 
and Schachner, 2004).
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1.6.1 Glycosylation important for agrin signalling?
One half of the apparent molecular weight of agrin on SDS-PAGE is based on protein mass 
and the other half is due to carbohydrates. Several groups therefore suggested that carbohydrates 
might also be important for agrin signaling. Initial experiments showed that heparin and heparan 
sulfates inhibit agrin signaling in muscle cells (Wallace, 1990) and agrin binding to α-dystroglycan 
(Campanelli et al., 1996, Gesemann et al., 1996). Moreover, muscle cells that are deficient in 
heparan sulfate biosynthesis are defective in agrin-induced AChR clustering (Gordon at al., 1993; 
Sugiyama et al., 1994; Bowen et al., 1996).
The involvement of carbohydrate chains of agrin in the binding of agrin to its physical recep-
tor can immediately be excluded, since the smallest active G3-B/z+ fragment has neither N- nor 
O-glycosylation sites. Conversely, it has been shown that the three LG-like domains of agrin can 
mediate binding to carbohydrates (Xia and Martin, 2002). Thus, agrin may bind to other proteins 
via their carbohydrate chains.
The selective expression of certain glycosyltransferases at synaptic sites in skeletal muscle, rais-
es the possibility that carbohydrate modifications of MuSK, expressed selectively in myotubes, 
may be essential for agrin to bind and activate MuSK. In experiments done by Watty and Burden 
(2002), N-linked glycosylation sites on MuSK were analyzed with regard to agrin activation. By 
mutating these sites and expressing mutant proteins in MuSK-deficient myotubes, they found 
that agrin activation of MuSK did not require the N-linked glycosylation sites on MuSK protein. 
These mutants, however, did posses a higher level of spontaneous activation, suggesting that N-
linked glycosylation serves to alter MuSK structure or function in some still unknown way. These 
results are consistent with observations made for TrkA, the receptor tyrosine kinase for nerve de-
rived growth factor (NGF), where non glycosylated TrkA receptors become constitutively active 
(Watson et al., 1999). Conversely, adding sialic acid or sialyl-N-acetylglycosamine, which ‘cap’ the 
end of the carbohydrate chains, to the culture medium of myotubes reduces agrin-induced AChR 
clustering (Grow and Gordon, 2000; Xia and Martin, 2002). Finally, a particular N-acetylglycos-
amine transferase that attaches specific ß-linked N-acetylglycosamine moieties to carbohydrate 
side chains is enriched at the NMJ and, when overexpressed throughout skeletal muscle, it causes 
the formation of ectopic AChR clusters and affects postsynaptic differentiation at the NMJ (Xia 
and Martin, 2002).
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1.7 Alternative splicing
Alternative splicing is a common mechanism for regulating gene expression in mammalian 
cells. Protein structure and activity is often altered by the variable inclusion of coding exons or 
portions of exons into an mRNA. Alternative splicing of pre-mRNAs is therefore a powerful and 
versatile regulatory mechanism that is used to enhance the information contained within a gene. 
An example for the highly complex splicing events is illustrated in the case of the ‘Down syndrome 
cell adhesion molecule’ (Dscam) of Drosophila melanogaster, where one single gene can give rise 
to over 38’000 different alternatively spliced mRNA isoforms, which is about 2-3 times the num-
ber of predicted genes in the entire organism. This issue would become even more complex, if we 
would consider also other RNA processing events, such as RNA editing for instance (reviewed in 
Graveley, 2001).
Some alternative splicing events appear to be constitutive, with mRNA variants coexisting at 
constant ratios in the same cell, whereas others are regulated in response to developmental or 
physiological cues. The consequences range from switching expression of a protein on and off 
(e.g. by including or excluding stop codons as in Sxl (Bopp et al., 1991)), to structural and func-
tional diversification of protein products (by including or excluding elements as small as a single 
amino acid, for example in Pax-3 and Pax-7 (Vogan et al., 1996)). Hence, alternative splicing is 
a versatile process that can be integrated with other regulatory mechanisms to generate complex 
genetic switches, to modulate cellular responses to developmental and physiological signals, to 
Protein Type of glycosylation Function of glycosylation
Dystroglycan O-linked (via Mannose) Laminin, agrin, perlecan, neurexin binding
 CT antigen (O-linked) Altered matrix/utrophin binding
Agrin GAG (Heparan sulfate) NCAM, laminin, FGF2 binding
  FGF2 signaling
 O-linked (via GalNAc) Musk signaling
MuSK N-linked Spontaneaus activity
NCAM Polysialyc acid (N-linked) Agrin binding
  Homophilic binding
V-gated Na Channel Sialic acid (N-linked) Voltage gating
Biglycan GAG (Chondroitin sulfate) Dystroglycan binding
Perlecan GAG (Heparan sulfate) Acetylcholinesterase binding
Acetylcholinesterase GalNac (linkage unknown) Unknown
Laminin N-linked Galectin, integrin binding
AChR N-linked Bungarotoxin binding
Table 1.1 | Potential roles of carbohydrates in synaptic protein function (reviewed in Martin 2003)
Abbreviations: GAG, glycosaminoglycan; NCAM, neural cell adhesion molecule; FGF-2, basic fibroblast growth factor 2; MuSK 
muscle-specific kinase; V-gated Na channel, Voltage-gated sodium channel; AChR, acetylcholine receptor.
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fine tune the function of regulatory factors, and to diversify the biochemical inventory within and 
between cells.
The mechanism of alternative splicing, is extensively used in the nervous system. Indeed, 
splicing events in the nervous system are known for a vast category of proteins, which include 
receptors for signaling molecules (e.g. MuSK, neurexin, alpha and beta subunit of integrins, fi-
broblast growth factor receptor (Ganju et al., 1995; Valenzuela et al., 1995; Missler and Südhof, 
1998; Fornaro and Languino, 1997; Ornitz et al., 1996; Shi et al., 1993)), signaling molecules (e.g. 
neurexins, neuregulins (reviewed in Missler and Südhof, 1998; Graveley, 2001; Lemke, 1996)), 
and extracellular matrix and cell adhesion molecules (e.g. agrin, laminin, fibronectin, neuroligin 
(Ruegg et al., 1992; Rupp et al., 1992; Thomas et al., 1993; Kornblihtt et al., 1996; Sherman et al., 
1998; Scheiffele et al., 2000).
The importance of alternative splicing is nicely illustrated also in processes which lead to the 
induction of the formation of the postsynaptic apparatus. In the early 90’ McMahan and col-
leagues could show that agrin is modulated by such events, and that the activity of agrin relies 
on one single exon, which is only 24 nt in length. Interestingly, agrin is expressed almost in the 
whole body, like brain, spinal cord, kidney, lung, blood capillaries, muscles and motor neurons 
for instance (Stone and Nikolics, 1995). But depending on its localization and the task agrin has 
to fulfill it is differently spliced.
MuSK is thought to be a part of the agrin receptor complex, but does not bind agrin itself (Glass 
et al., 1996). Moreover the putative coreceptor MASC has not been identified yet. Alternative 
splicing therefore raises the possibility that MuSK expresses a splice variant which confers direct 
binding to agrin. Unfortunately, in contrast to agrin, splice variants of MuSK have poorly been 
characterized.  So far there are reports about three different splice sites in the extracellular part 
and one in the intracellular part of MuSK (Ganju et al., 1995; Valenzuela et al., 1995; Hesser et al., 
1999). Their function and distribution is totally unknown and has still to be elucidated.
1.8 Aim of the thesis
In this thesis I aimed in elucidating of how agrin induces postsynaptic differentiation of the 
neuromuscular junction. In a first approach, I tried to identify the agrin receptor and other pro-
teins associated with the muscle specific kinase in order to understand of how agrin activates the 
signaling pathway leading to AChR clustering. In a second project, the importance of the B/z 
splice insert in activating the MuSK pathway was analyzed. Moreover, I found a correlation be-
tween the ability of agrin to bind to α-DG and its MuSK phosphorylating activity, showing that 
α-DG plays an important auxiliary role in activation of the agrin receptor complex.
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Chapter 2
Application of the split-ubiquitin membrane 
yeast two-hybrid system to investigate MuSK 
interactors
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2.1 Summary
Since the postulation of the agrin-hypothesis by McMahan in 1990, many groups were trying 
to unmask the identity of the agrin receptor. First, α-DG was thought to be the physical receptor 
as it was found to be the main binding protein of agrin on the muscle surface (Bowie et al., 1994; 
Gee et al., 1994), but very soon this hypothesis was disproved. Right after MuSK was proposed to 
be the agrin receptor, as the release of agrin by the nerve leads to rapid activation of MuSK to me-
diate AChR clustering (Glass et al., 1996). Furthermore, it was shown that both agrin and MuSK 
are essential for synapse formation, as mice deficient for agrin or MuSK lack any pre- and post-
synaptic specialization (Fig. 1.5; DeChiara et al., 1996; Gautam et al., 1996). Importantly, postsyn-
aptic clusters of AChR are completely absent in MuSK-deficient mice (DeChiara et al., 1996). It is 
now clear that MuSK is the signaling component activated by neural agrin. However, MuSK does 
not bind directly to neural agrin indicating that activation of MuSK depends on a muscle-associ-
ated specific component (MASC; Glass et al., 1996). Many groups tried to identify the nature of 
MASC using many different approaches unsuccessfully. We now use a new approach based on 
the method of the yeast two-hybrid system to identify the so long sought agrin receptor and other 
MuSK associated proteins.
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2.2 Introduction
The neuromuscular junction is a synapse between motor neurons and skeletal muscle fibers 
that exhibits the high degree of subcellular specialization characteristic of chemical synapses (Hall 
and Sanes, 1993; Sanes and Lichtman, 1999, 2001). Due to its relative simplicity and accessibil-
ity, the NMJ has been studied extensively as a model of synaptogenesis. A hallmark of the NMJ 
is the high concentration of synaptic proteins including AChRs in the postsynaptic membrane 
that guarantees fast and accurate neurotransmission (Burden, 1998; Colledge and Froehner, 1998; 
Fallon and Hall, 1994, Sanes and Lichtman, 2001). In the absence of innervation, the muscle seems 
to be prepatterned (Ferns and Carbonetto, 2001; Lin et al., 2001; Yang et al., 2001, 2000). Small 
AChRs clusters aggregate in the central region of the muscle, forming a central band that appears 
to be wider and more poorly defined than in innervated muscle. Upon innervation, AChR clus-
ters are restricted to a narrow central band. Studies of regenerating synapses demonstrate that 
the synaptic basal lamina contains a signal to cause redistribution of AChRs (McMahan et al., 
1992). This signal is believed to be agrin, a 225 kD polypeptide that is expressed in motoneurons, 
transported to presynaptic nerve terminals, and deposited in the basal lamina in the synaptic cleft. 
Neural agrin induces postsynaptic differentiation in cultured muscle cells (Campanelli et al., 1991, 
Tsim et al., 1992, Wallace 1989). Studies of mutant mice convincingly demonstrate that agrin is 
essential for AChR clustering in the membrane opposite the presynaptic terminals (Gautam et al., 
1996, Ruegg and Bixby, 1998).
MuSK, a receptor tyrosine kinase, was discovered because of its abundance in the synaptic-rich 
Torpedo electric organ, whose principal cells are modified muscle cells that are innervated by 
cholinergic synapses (Jennings et al., 1993). Studies of the MuSK mouse homologue reveal that 
MuSK is specifically expressed in skeletal muscle and is colocalized with AChRs in the postsyn-
aptic membrane of the NMJ (Valenzuela et al., 1995). Agrin activates MuSK, and expression of a 
dominant-negative form of MuSK inhibits agrin-induced cluster formation in cultured myotubes 
(Glass et al., 1996). The extracellular domain of MuSK inhibits agrin-induced AChR clustering in 
C2C12 muscle cells (Glass et al., 1996). Moreover, MuSK-/- mice fail to form the NMJ (DeChiara 
et al., 1996; Lin et al., 2001; Yang et al., 2001). Agrin was unable to induce AChR clustering in 
muscle cells of MuSK mutant mice (Glass et al., 1996), but agrin sensitivity was restored by intro-
duction of wild-type MuSK into MuSK-/- myotubes (Herbst and Burden, 2000; Zhou et al., 1999). 
These results demonstrate that MuSK is essential for agrin-induced AChR clustering. Addition-
ally, it was also demonstrated that agrin failed to induce MuSK phosphorylation in myoblasts or 
if expressed of in heterologous cells, like fibroblasts (Glass et al., 1996). This shows that to activate 
MuSK a muscle specific component is needed, which was termed MASC. MuSK is therefore be-
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lieved not to be the physical receptor itself but rather composes the transducing part of the recep-
tor complex (Glass et al., 1996). In response to agrin, MuSK undergoes tyrosine phosphorylation 
(Glass et al., 1996), which may create docking sites for signaling molecules or contribute to proper 
folding of the kinase. For example, the juxtamembrane tyrosine (Y553) is required for agrin-
induced AChR clustering (Herbst and Burden, 2000; Zhou et al., 1999). Agrin stimulates tyro-
sine phosphorylation of AChRs, probably via Src kinase, leading to an increase of AChR clus-
ters (Willimann and Fuhrer, 2002). In addition, activities of intracellular enzymes increase in the 
muscle in response to agrin. For example, Rho GTPases are activated by agrin, and inhibition of 
Cdc42 or Rac blocks agrin-induced AChR clustering (Weston et al., 2000, 2003). Downstream 
of the small GTPases may be p21-activated kinase (PAK), a cytoplasmic kinase involved in cyto-
skeleton regulation (Luo et al., 2002). PAK is activated by agrin in a manner dependent on Cdc42 
or Rac1 and is required for agrin/MuSK-mediated AChR clustering (Luo et al., 2002). Moreover 
PAK interacts with disheveled (dvl1) which itself is associated with MuSK. Overexpression of Dvl 
mutants incapable of interacting with MuSK or PAK inhibited agrin-induced PAK activity (Luo 
et al., 2002). This complex might help to recruit PAK into the subsynaptic compartment for ef-
ficient PAK activation. These observations point out a signaling pathway involving Rho GTPases 
and PAK in regulating AChR clustering. An important but unsolved question is the identity of the 
mechanism immediately downstream of MuSK that is essential to activate GTPases and/or trigger 
AChR clustering.
To gain insights into molecular mechanisms that lead to activation of MuSK by agrin and to 
downstream signaling, which lead to AChR clustering upon agrin induction, we searched for pro-
teins that interact with MuSK.
2.2.1 The yeast two-hybrid system
The analysis of membrane protein interactions is difficult because of the hydrophobic nature of 
these proteins, which often renders conventional biochemical and genetic assays fruitless. Tradi-
tionally, biochemical methods such as co-immunoprecipitation, crosslinking, and co-purification 
by chromatography have been used to investigate the composition of the MuSK receptor complex, 
hence without success. Biochemical methods often require harsh treatments for cell disruption 
and therefore may not preserve weak and/or transient interactions. To address technical diffi-
culties associated with the biochemical characterization of physical protein-protein interactions, 
alternative genetic methods have been developed. A very powerful genetic method for the study 
of protein-protein interaction is the yeast two hybrid system (YTH), which is based on reconsti-
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tution of functional transcription factor through a defined protein-protein interaction (Fig. 2.1; 
Fields and Song, 1989; Chien et al., 1991; Hollenberg et al., 1995).
The assay is conducted in Saccharomyces cerevisiae, the bakers yeast, and uses transcription of 
yeast reporter genes to measure the protein interaction, which takes place in the nucleus. One of 
two proteins is expressed as a fusion to a DNA-binding domain from a transcription factor (TF), 
and the other is expressed as a fusion to a transcription activation domain (AD). If the fusion pro-
teins interact, they activate transcription of specially designed reporter genes that carry binding 
sites for the DNA binding partner (Fig 2.1; reviewed in Brent and Finley, 1997).
Despite significant progress in development of the YTH system, the analysis of interactions 
between membrane proteins remained a significant challenge because of the transmembrane do-
main of these proteins which render them insoluble (Auerbach et al., 2002; Stagljar and Fields, 
2002). In addition, integral and membrane associated proteins often undergo posttranslational 
modifications or oligomerize via interactions between their transmembrane domains, all of which 
is unfavorable for a traditional YTH assay (reviewed in Fields and Sternglanz, 1994).
To overcome these problems, Stagljar and colleagues have adapted the YTH system for mem-
brane proteins. In recent experiments they have shown that the modified split-ubiquitin system 
can be used as a genetic assay for the in vivo detection of interactions between two transmembrane 
proteins, nicely shown with the example of the essential subunits of the yeast oligosaccharyl 
transferase membrane protein complex, Ost1 and Wbp1 (Stagljar et al., 1998; Stagljar and te Hes-
sen, 2000).
This so-called split-ubiquitin membrane YTH (mYTH) system takes advantage of the split 
ubiquitin approach first described by Johnsson and Varshavsky (1994) (Fig. 2.2). It is based on 
the ability of the N- and C-terminal halves of ubiquitin, Nub and Cub, to reassemble into a quasi-
native ubiquitin (split-ubiquitin). Ubiquitin-specific proteases (UBPs), present in the cytosol and 
nucleus of all eucaryotic cells, recognize such reconstituted ubiquitin but not its halves and cleaves 
RNA pol IIDBD
AD
HIS, ß-gal
X
Y
bait
prey
Figure 2.1 | The principle of the yeast two-hybrid system. 
ProteinX is expressed as a fusion to the DNA-binding domain 
(DBD) and constitutes the bait. The DBD-X fusion protein is 
bound to the operator sites in the promoter region but does 
not activate transcription of the downstream reporter gene 
because it lacks an activation domain (AD). The interaction 
of DBD-X with its partner Y fused to an AD recruits the AD-Y 
fusion protein (prey) to the promoter where it forms a func-
tional transcriptional activator. Consequently, transcription 
of the reporter gene is switched on.
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off a reporter protein that is linked to the C-terminus of Cub. The assay is designed in such way 
that the association of Nub and Cub is only efficient if the ubiquitin halves are linked to two pro-
teins that interact in vivo (Fig2.2 d, e). This is achieved by the introduction of a point mutation 
into the N-terminal moiety of ubiquitin, which converts Isoleucine at position 13 to a Glycine 
(NubG), resulting in a decreased affinity between Cub and NubG (Fig 2.2 a, d).
In the split-ubiquitin mYTH system, one protein of interest, the bait X, is fused the Cub do-
main, followed by a reporter protein which is an artificial transcription factor (TF) composed of 
LexA, the DNA binding domain from the bacterial repressor LexA (Brent and Ptashne, 1985), 
and VP16 the activation domain (Sadowski et al., 1988; Stern Tanaka and Herr, 1989; Triezenberg 
1988a, 1988b), and the other, the prey Y, is fused to NubG. To detect a potential interaction be-
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Figure 2.2 | Principle of the split-ubiquitin system.
(a) A ribbon diagram of Ubiquitin (Ub; Vijay-Kumar et al., 1987; Kraulis, 1991), with its two subdomains colored blue and green (as in b-e). The 
scissor denotes the site of either a 68-residue insertion or a cut between the subdomains. Some of the residue numbers are indicated. Ile-13 in 
the second strand of the ß-sheet is mutated to Gly, whereas it normally interacts with the opposed hydrophobic face of the α-helix. (b) A newly 
formed Ub moiety bearing an insertion (wavy brown line) between its N-terminal (Nub; green) and C-terminal (Cub; blue) subdomains are linked 
to a reporter protein (Re; orange). This insertion does not detectably interfere with the Ub folding, which is required for the in vivo cleavage 
of the fusion by Ub-specific preoteases (UBPs), yielding the free reporter. (c) When Nub and Cub are coexpressed as separate fragments, with 
Cub still linked to the reporter, Ub is reconstituted in vivo to give quasi-native Ub recognizable by UBPs. (d) In vivo reconstitution of Ub from 
its separate, coexpressed fragments did not occur with a mutant Nub fragment, denoted as Nubm, that contains a single-residue replacement 
at position 13. Conformational destabilization of Nubm relative to its wild-type counterpart Nub is indicated by the altered shape of the Nubm 
subdomain. (e) The mutated Nubm supports reconstitution if the two Ub fragments are linked to polypeptide P1 and P2 (green and blue, respec-
tively) that interact in vivo. Reduced conformational stability of Ub that has been reconstituted with Nubm instead of Nub is denoted by a gap 
between the Ub subdomains. Adapted from Johnsson and Varshavsky,1994.
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tween these two proteins X and Y, the two plasmids are introduced into a suitable yeast reporter 
strain. Interaction of both proteins results in the assembly of split-ubiquitin and the proteolytic 
release of the TF by UBP’s, allowing the TF to enter the nucleus, leading to activation of the yeast 
reporter genes (Fig 2.3; Stagljar et al., 1998; Thaminy and Stagljar, 2004).
We used the mYTH system to address the question what proteins interact with MuSK, with 
the main goal to identify the agrin receptor. In order to stabilize the formation of the complex, the 
host strain was designed in such a way that agrin is constitutively synthesized and secreted out of 
the cell, where it is enabled to interact with the receptor complex (Fig 2.3).
MuSK
muscle-cDNA-library
RNA pol II
Cub Nub
?
Prot. A
VP-16
Lex A
HIS, ß-gal
Agrin-LG3(B8)
Agrin-LG3(B8) -Plasmid
Nucleus
(bait) (prey)
Prot. A
Lex A
VP-16
Figure 2.3 | Principle of membrane-based split-ubiquitin system used to screen for MuSK interactors.
MuSK protein is fused to the Cub domain followed by the reporter composed of protein A and the artificial transactivator LexA-VP16. Since the 
transactivator is immobilized at the membrane, it can not reach the nucleus and is unable to activate the reporter genes. Co-expression of an 
interacting protein Y derived from a muscle cDNA library fused to NubG, triggers the re-association of split-ubiquitin, followed by cleavage and 
release of the transactivator. Upon diffusion to the nucleus, the transactivator activates the reporter genes, conferring the cells the capability 
to grow on selective medium lacking histidine and to become blue in a b-galactosidase assay. The system also expresses the LG3B8 domain of 
agrin to ensure an interaction of MuSK and the unknown agrin co-receptor.
Investigation of MuSK interactors using the split-ubiquitin YTH
41
2.3 Material and Methods
Construction of plasmids 
Plasmid sequences and detailed construction schemes of all constructs used for this work are 
available on request. All plasmids were verified by sequencing, and the expression of all constructs 
was checked by western blot analysis or immunehistochemistry using suitable antibodies. 
In brief, pNsk2-Cub-PLV was first constructed in bluescript pKS+ by opening the vector with 
EcoRI/BamHI and ligating with the 5’ fragment of Nsk2 amplified by PCR and subsequently 
digested the same way. The PCR fragment was generated with sense oligo Eco_Nde_Nsk2s46 
(AACATAGAATTCCATATGAGAGAGCTTGTCAACATT) and antisense oligo Nsk2_as685 
(ATTCAGGAGCACGCAGGAT) using pNsk2
0
CP (previously described in thesis of Dominik 
Hauser) as a template. The 3’ fragment of Nsk2 was then inserted by amplification with oligos 
Nsk2_504s (CTGGATCAAGGGGGACAA) and as2640Nsk2_Xba (ACTAGTCTAGAGA-
CACCCACCGTTCCCTCT) using pNsk2
0
CP as template. The PCR fragment was then cleaved 
with  BamHI/XbaI and ligated into the vector previously constructed plasmid digested with 
BamHI/XbaI. pNsk2 in Bluescript was then digested with endonucleases EcoRI/XbaI and moved 
to pY-Cub-PLV vector previously opened with EcoRI/XbaI. pNsk2-NubG was constructed in 
analogy to pNsk2-Cub-PLV other than for the amplification of the 5’ fragment of Nsk2 the an-
tisense oligo as2640Nsk2_SmaI (ACTATCCCGGGACACCCACCGTTCCCTCT) was used. 
Subsequently the whole Nsk2 fragment was moved to the pX-NubG plasmid by cleaving with 
endonucleases Nde and SmaI. 
pNsk2neuTNsk2-Cub-PLV was generated by inserting the transmembrane region of neuT by 
cleaving MuSKneuTMuSK construct (Jones et al., 1999) with endonucleases HindIII and BlpI. 
This fragment was purified and inserted into the pNsk2-Cub-PLV construct opened with HindIII/
BlpI. The generation of pNsk2neuTNsk2-NubG was done by a triple ligation. The vector pNsk2-
Cub-PLV was opened with MscI and HindIII. One insert was generated by digesting pNsk2-Cub-
PLV with endonucleases MscI and BlpI, the second fragment containing the transmembrane do-
main of neuT was generated by cleavage of the MuSKneuTMuSK construct with HindIII and BlpI 
endonucleases. The generation of pCIneo-Nsk2-NubG and pCIneo-Nsk2-Cub-PLV constructs were 
accomplished by moving the inserts from the bait and the prey plasmids into pCIneo vector respec-
tively. The construction of pSS-MFα1-C21B8 was performed by amplification of signal sequence 
of MFα1 using oligos s_MF-alpha1 (CATAAGCTTATGAGATTTCCTTCAATTTTTACTGC ) 
and as_MF-alpha1 (ACATGGATCCAGCTAATGCGGAGGATGCTG) and pDA6300 (Dulic et 
al., 1991; Tan et al., 1993) as a template. C21B8 fragment of agrin was generated by cleaving with 
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a previously described (Alexandrescu et al., 2001) agrin construct with endonucleases BamHI 
and EcoRI. The vector was opened with HindIII and EcoRI and the MFα1 fragment was digested 
HindIII and BamHI. After agarose gel purification the 3 DNA pieces were ligated to give the final 
construct.  pOst1-NubG and pWbp1-Cub-PLV were described previously (Stagljar et al., 1998). 
pGAD was a gift from Igor Stagljar.
Yeast strains, media
Standard yeast media and techniques were used (Sherman, 1979,1991). For selection of 
plasmids, dropout media containing all except the specified amino acids were used. All plasmids 
were transformed into yeast by lithium acetate transfomation (Ito et al., 1983, Schiestl and Gietz, 
1989).
All constructs were expressed in Saccharomyces cerevisiae modified L40 (Vojtek et al., 1993) or 
a derivative TAT7 (Sternglanz).
L40: (MATa trp1 leu2 his3 LYS2::lexA:HIS3 URA3::lexA-lacZ)
TAT7: (MATa trp1 leu2 his3 ura3 LYS2::lexA:HIS3 URA3::lexA-lacZ)
MCY001: Background L40 (MATa trp1 leu2 his3 ura3 LYS2::lexA-HIS3, URA3::lexA-lacZ, 
LEU2::pNsk2-Cub-PLV[LEU2], URA3∆::kanMX6[G418], pAgrinC21B8[URA3])
MCY003: Background YG0673 (Stagljar et al., 1998) (MATa trp1 leu2 his3 ura3 LYS2::
lexA-HIS3, URA3::lexA-lacZ, wbp1::pRS305(∆wbp1-Cub-PLV), URA3∆::kanMX6[G418], 
pAgrinC21B8[URA3])
MCY006: Background TAT7 (MATa trp1 leu2 his3 ura3 LYS2::lexA-HIS3, URA3::lexA-lacZ, 
LEU2::pNsk2-Cub-PLV[LEU2], pAgrinC21B8[URA3])
MCY009: Background TAT7 (MATa trp1 leu2 his3 ura3 LYS2::lexA-HIS3, URA3::lexA-lacZ, 
LEU2::pNsk2-Cub-PLV, WBP1::pRS305-Wbp1-CubPLV[LEU2], pAgrinC21B8[URA3])
Yeast knockout
In order to knock out the URA3 gene, PCR-based gene disruption was performed as previously 
described by Wach et al. (1994, 1996). A 1.5 kb PCR fragment was generated by using pFA6-
KanMX6 plasmid (Wach et al 1994) as template and two primers (s_URA_Kan6 AACCAACTG-
CACAGAACAAAAACCTGCAGGAAACGAAGATAAATCCGTACGCTGCAGGTCGAC and 
as_URA_Kan6 CCACACCGTGTGCATTCGTAATGTCTGCCCATTCTGCTATTCTGTATC-
GATGAATTCGAGTCTG) with 18-19 nucleotide homology to the multiple cloning site of pFA6-
kanMX6. These primers have additional nucleotides which were either homologous to the region 
immediately upstream or downstream of the URA3 gene. The PCR product was purified and trans-
formed into the L40 strain. Transformed cells were resuspended in 1 ml YPAD and preincubated 
for 3-4 hours at 30°C. Subsequently cells were collected by centrifugation, resuspended in 200µl 
deionized water and plated on YPAD-G418 (200mg/ml) containing agarose-plates.
Investigation of MuSK interactors using the split-ubiquitin YTH
43
Protein extraction and western blot analysis
Cells were grown at 30°C to OD
600
 of 0.8-1.0 in appropriate liquid dropout medium. Proteins 
were extracted essentially according to Horvath and Riezman (1994). Cells were pelleted washed 
once with sterile water and then resuspended in 200µl breaking buffer (50mM Tris-HCl pH 8, 
100mM NaCl, 1mM EDTA, 2% SDS, 1µg/ml each of Antipain, Leupeptin, Pepstatin A, Aprotinin 
and Chymostatin) and the halve amount of 1000µm glass beads (Sigma) was added. The samples 
were vortexed 3 times for 20s at full speed using the fast-prep machine from bio101. Subsequently 
the samples were centrifuged at full speed in a benchtop centrifuge (Eppendorf) for 2 min. 250µl 
supernatant were transferred into a new tube and centrifuged again for 2min at full speed. 200µl 
of the supernatant were then re-transferred into a fresh tube where 200µl of 2x reducing SDS-
samplebuffer was added to the cell-lysate and subsequently boiled for 5 min at 95°C. Samples 
were then centrifuged again and 50µl were for separation by 7.5% SDS-PAGE (Laemmli, 1970), 
and transferred to nitrocellulose (Towbin et al., 1979). Membranes were probed with 194T anti-
MuSK antibody at 1:5000, with anti-HA 12CA5 antibody at 1:2000 or with anti LexA antibody 
at 1:2000. The appropriate horse radish peroxidase-conjugated secondary antibody was used at a 
dilution of 1:5,000 (Jackson Laboratories). Immunoreactive protein bands were visualized by the 
ECL detection method (Pierce).
Analytical PCR
A small amount of yeast colony material was resuspended in 5µl of nanopure water in a 200µl 
PCR tube. The yeast cells were boiled for 5 min at 95°C. Subsequently 20µl PCR mastermix (2.5 
µl 10x Taq PCR buffer (Roche), 2.5µl 2mM dNTPs, 0.25µl 100µM mmUb1a_fw primer [5’-AT-
GCAGATCTTYGTGAARACC-3’], 0.125µl 100µM mmUb2a_rv primer [5’-TTGTAGTCTGA-
CAGGGTGCGG-3’], 0.125µl 100µM mmUb2b_rv primer [5’-TTGTAATCAGAGAGRGTGC-
GG-3’], 0.1µl 5U/µl Taq DNA Pol and 14.4µl nanopure H
2
O) were added and cycled as following: 
95°C hotstart, 35 cycles [95°C 30s, 60°C 30s, 72°C 30s]. 15µl of the reaction mixture were then 
analyzed on a 2% agarose gel. The expected fragment size for ubiquitin containing clones was 
179bp.
Library screen
Cells were grown at 30°C to OD
600
 = 1.0 in 600ml liquid dropout medium lacking Trp and Ura 
and supplied with Ade. Cells were centrifuged and washed with sterile water. Then the cells were 
centrifuged again and resuspended in 10ml 100mM LiAc and incubated for 30 min. The cells 
were then collected by centrifugation and the following reagents were added strictly in the sub-
sequent order, 24ml 50% PEG 4000, 3.6 ml 1M LiAc, 1ml single stranded salmon sperm carrier 
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DNA (10mg/ml, GibcoBRL), 50µg library plasmid DNA (X) and finally 7.4ml – Xml library DNA 
sterile H
2
O. The transformation mix is then vigorously vortexed until the cells are homogeneously 
resuspended, and thereafter aliquoted in 100 sterile eppendorf tubes. The aliquots were incubated 
at 30°C for 30 min and then heat shocked for 35min at 42°C. Subsequently cells were collected by 
centrifugation, resuspended in 200µl sterile water and plated on agarose-plates lacking Trp, Ura, 
Leu, His and supplied with 10mM 3-Amino-1,2,4-triazole (3-AT).
β-Galactosidase Activity Tests 
Cells were grown for two days at 30°C on dropout agar plates lacking leucine, tryptophan 
and uracil. Then the colonies were lifted onto a Whatman filter. Subsequently the cells were 
permeabilized by dipping the filters into liquid nitrogen for 1 min. After thawing, the filters with 
colonies up, were overlaid with 0.5% agarose in TBE containing 0.1 mg/ml 5-bromo-4-chloro-ß-
D-galactopyranoside (X-Gal), and incubated at RT for 1-24 h.
Construction of a cDNA library
As the split-ubiquitin YTH method allows to screen for integral membrane proteins, two cDNA 
libraries need to be constructed, one for type I and another for type II transmembrane proteins. 
This is due because the proteins expressed by the library are linked in frame to the NubG reporter 
at the intracellular part of the protein. But depending on the type of transmembrane protein, they 
have their C-terminus either inside or outside the cell. Therefore to cover all types of proteins two 
different libraries have to be constructed. Subsequently, typeI-library is used to call the library for 
typeI transmembrane proteins and typeII-library for typeII transmembrane proteins.
Total RNA was isolated from six 15cm dishes of cultured C2C12 myotubes, using TRI-Reagent 
(MRC, Molecular Research Center Inc.). Total RNA was subsequently purified in two steps. First 
RNA was isopropanol precipitated and subsequently rinsed with ethanol. Total RNA was then 
resuspended in binding buffer (10mM Tris-HCl (pH 7.5), 1mM EDTA, 0.3M NaCl, 0.1% (w/v) 
SDS). Thereafter Poly(A+)-RNA was isolated using an Oligo(dT) Cellulose Column (GibcoBRL, 
Life Technologies) strictly according the manufacturers protocol. For the preparation of cDNA, 
the ‘SuperScript™ Choice System for cDNA Synthesis’ (GibcoBRL, Life Technologies) was used. 
For the experimental procedure the manufacturers protocol (Cat. Series 18090) was strictly fol-
lowed. According to the protocol, in following variable steps subsequent decisions were taken: 
(a) for the first strand synthesis 5µg of poly(A+)-RNA was primed with 150ng random hexamers, 
and (b) in the purification step to remove the excess of EcoRI-adapters from cDNA by column 
chromatography, fractions 6-12 were collected. The fractions were pooled and re-purified twice 
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over two different size exclusion columns (Clontech). In a first step chromaspin-1000 and in a 
second step chromaspin-400 was used. This additional step was done to totally deplete the cDNA 
from adaptor-molecules, as their presence lower tremendously the ligation efficiency with the 
library-plasmid. Prior ligation, 5 µg of each of the two library plasmids, pX-NubG and pNubG-
X (I. Stagljar), were linearized using EcoRI (NEB) and dephosphorylated using calf intestinal 
phosphatase (Roche), and the cDNA was concentrated by ethanol precipitation. To ensure a max-
imum ligation efficiency the vector to insert ratio was determined by doing some test ligations. 
Ligation was then performed overnight at 4°C using 5x concentrated ligase (Roche). Moreover, 
to guarantee a maximum and reliable transformation efficiency, commercial electrocompetent 
bacteria DH10B (GibcoBRL, Life Technologies) were used to electroporate the previously pre-
cipitated ligation mix. The electroporation was carried out using following settings, 1.8kV, 25µF 
and 200Ω. Immediately after electroporation pure LB was added to the cells and incubated for 
recovery for 30 min at 37°C. Then each library was distributed on 125 15cm LB-agarose plates 
containing 100µg/ml ampicillin (Sigma). The number of plates was previously determined and 
chosen the way that every plate contained about 40’000 single colonies. The calculated complexity 
resulted in 5x106 independent clones for each library. The colonies were washed off with pure LB 
and pooled. One part was used to isolate the plasmids with a maxiprep kit (Qiagen) and the rest 
was supplied with glycerol and frozen down at –70°C. To check the quality of the library, a part of 
the isolated plasmids of each library was retransformed back into XL1-blue (Bullok et al., 1987). 
From 12 single colonies the plasmids were digested and the dimension of the inserts was deter-
mined. About 60% of all plasmids contained an insert, with an average size of 1.3 kb (Fig. 2.4).
pX-HA-NubG-library (typeI) M pNubG-HA-X-library (typeII)
Figure 2.4 | Percentage of plasmids containing an insert and insert size of the cDNA libraries.
Isolated plasmids from type I- and type II-libraries were back-transformed into bacteria and streaked onto selective plates. 12 clones 
were randomly picked for each library and the purified plasmids subjected to restriction digestion. The digested clones were run 
on a 1% agarose gel to identify the insert size and the number of clones that contain an insert. ~60% of plasmids of both libraries 
contained an insert with an average size of ~1200 bp. The DNA-ladder: red, 3000bp; orange, 2000bp; yellow, 1600bp; green 1000bp; 
blue, 500bp. 
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2.4 Results
2.4.1 MuSK and agrin are expressed in yeast cells
Even though yeast cells are also eucaryotic cells, the protein synthesis and export machinery is 
similar but not the same as in mammalian cells. Therefore, not all mammalian proteins are suit-
able for expression in yeast. Proteins might not be folded correctly, lack some post-translational 
modifications or be mistargeted due to a signal sequence which is not recognized by the yeast cell 
(Lee and Lee, 2004). Additionally, mammalian proteins can also become toxic to yeast since usu-
ally strong promoters are used for protein expression and enormous amounts of protein is present 
in the yeast cell.
Prior to expressing MuSK in yeast, the MuSK bait and prey constructs were subcloned into a 
mammalian expression plasmid and analyzed for correct expression in COS-7 cells. As shown in 
Fig 2.5, MuSK is correctly expressed at the expected size as bait (pMuSK-Cub-PLV) and as prey 
(pMuSK-NubG) protein (Fig. 2.5 a), and is additionally phosphorylated upon overexpression (Fig 
2.5 b). Thereafter, pMuSK-Cub-PLV and pMuSK-NubG were expressed in yeast. Their correct 
expression was also confirmed by western blot analysis (Fig 2.5 c). In contrast, agrin expression 
and functionality was analyzed by measuring its clustering activity on cultured C2C12 myotubes. 
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Figure 2.5 | Analysis of chimeric MuSK proteins expressed 
in COS-7 and yeast cells.
COS-7 cells were transiently transfected with pMuSK-NubG 
(prey), pMuSK-Cub-PLV (bait) and mock. MuSK containing 
fusion proteins were immunoprecipitated using the 194T 
anti-MuSK antisera and run on a 3-12% PAGE. Western 
blots were probed with the same antibodies against MuSK 
(a) and with antibodies against phosphotyrosine (b). (c) 
The same constructs were analyzed after transformation 
into yeast. Total yeast extract was loaded on a 3-12% 
PAGE. The Western blot was probed with 194T antibody. 
(d) The L40 reporter strain was transformed with LG3B8 
agrin and grown in liquid media. The cells were broken 
up without detergent and the supernatant was concen-
trated. The concentrated supernatant and the cell ex-
tracts were given to cultured myotubes. After 16h, AChR 
clusters were visualized with rhodamine-conjugated a-
bungarotoxin (red). As negative control the wild-type L40 
(L40wt) strain and as positive control purified N25C95A4B8 
agrin was used. Scale bar 50µm.
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Yeast extract and concentrated supernatant yeast medium, from agrin expressing and wildtype 
L40wt cells, was mixed with differentiation medium for C2C12 cells in a ratio 1:1. The extracts 
were given to differentiated C2C12 cells and incubated for 16h. As shown in figure 2.5 d, yeast 
extract that was previously transformed with the agrin construct shows similar clustering activity 
as 1nM purified N25C95A4B8 agrin. In contrast extract from L40wt showed only some rare spon-
taneous AChR clusters. Thus, we can conclude that MuSK and agrin are correctly expressed in 
yeast cells.
2.4.2 Proof of concept
In a first step it was important to show that the bait itself would not activate the system. There-
fore L40wt was transformed with the MuSK-bait construct and two different control preys con-
taining either MuSK or Wbp1. As depicted in table 2.1, nor the bait alone, nor coexpressed with 
pMuSK-NubG or the other control prey pWbp1-NubG, could activate the reporter genes. These 
results show that the bait does not interact unspecifically with the control preys. Furthermore this 
is an indication that the bait is correctly targeted to the membrane, otherwise some degradation 
products, since not correctly targeted proteins which are in part in the cytosol, can activate the 
reporter genes by diffusion to the nucleus (personal communication with I. Stagljar).
After demonstrating that the bait and agrin are correctly synthesized, we next performed ex-
periments to show that the specific interaction of the bait with some other protein can activate 
the reporter genes. Unfortunately, until the timepoint when the project was started, no physical 
interactor of MuSK was known. Therefore we took advantage of the knowledge about RTKs. An 
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Figure 2.6 | MuSKneuTMuSK-Cub-PLV self dimerizes 
with MuSKneuTMuSK-NubG.
The L40 reporter strain was transformed with 
pMuSKneuTMuSK-Cub-PLV and pMuSKneuTMuSK-
NubG. To analyze the interaction between the con-
trol bait and prey, 6 clones were randomly picked and 
streaked on plates containing X-Gal and lacking leucine, 
tryptophane and histidine (-LTH). All clones grew on 
–LTH plates and three of them turned blue. As positive 
control CTD 21 was used, a clone that growths on –LTH 
and shows b-Gal activity (gift from I. Stagljar)
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overall accepted model for most of the RTKs is, that ligand induced dimerization of monomeric 
RTK leads to transphosphorylation and activation (reviewed in Schlessinger, 2000). Furthermore, 
it was also shown that chimeric MuSK receptors, containing the transmembrane domain of neuT, 
an oncogenic variant of the neu/erbB2 receptor, resulted in a constitutively active form of MuSK 
which leads to spontaneous homodimerization of the receptor (Jones et al., 1999). Based on this 
knowledge we constructed a chimeric bait and prey where the transmembrane domain of MuSK 
was replaced by the one neuT. These constructs were then transformed into L40wt strain and 
analyzed on selective plates. Only those clones which contained the constitutively active form of 
MuSK as bait and prey did grow on –leucine, tryptophane, histidine (-LTH) selective plates and 
were positive for ß-Galactosidase (details in table 2.1, Fig 2.6).
These experiments show that the system is tight and can be used for screening.
bait prey -L -LT -LTH β-Gal comment
pMuSK-Cub-PLV  ++   -- the bait is not selfactivating (an integration 
(linearized)       vector has to be linearized prior transformation
      in order to allow homologous recombination).
pMuSK-Cub-PLV
(non linearized)  --   -- the non-linearized bait will not integrate and
      therefore doesn’t grow
pX-Cub-PLV  ++   ++ The vector alone is not targeted to the membrane.
(linearized empty vector)      Thus the reporter is soluble and can activate the
      reporter genes.
pGAD (CEN/ARS)  ++   -- Positive control for growth
pWbp1pp-Cub-PLV  ++   -- Control bait (Stagljar et al., 1998)
      
pMuSK-Cub-PLV pMuSK-NubG ++ ++ -- -- By overexpression alone the reporter is not
(linearized)      cleaved off
pMuSK-Cub-PLV pOst1-NubG ++ ++ -- -- Control prey does not interact with bait
(linearized) 
pWbp1p-Cub-PLV pMuSK-NubG ++ ++ -- -- Control bait does not interact with MuSK
pWbp1p-Cub-PLV pOst1-NubG ++ ++ ++ ++ Control bait interacts with control prey
      (Stagljar et al., 1998)
pMuSKneuTMuSK-Cub-PLV  ++   -- Constitutively active form of MuSK
      is not selfactivating
pMuSKneuTMuSK-Cub-PLV pMuSK-NubG ++ ++ -- -- Constitutively acting form is not interacting
      with wilde-type MuSK
pMuSKneuTMuSK-Cub-PLV pMuSKneuTMuSK-NubG ++ ++ ++ ++ Constitutively active form of MuSK is needed
      as prey in order to activate the reporter  
Abbreviations: -L: SD-plates -leucine; SD-plates-LT: -leucine, tryptophan; SD-plates -LTH: -leucine, tryptophyne, histidine; ß-Gal: ß-galactosi-
dase. 
Table 2.1 | Summary of positive controls done with the L40wt reporter strain. Different prays were tested with several baits and their growth 
was analyzed on selective plates. Interactions was additionally tested for ß-Gal activity.
Chapter 2
50
2.4.3 Screening 
Finally, after all controls were done successfully, a screen for type I transmembrane proteins 
was carried out under the supervision of I. Stagljar and the help of S. Thaminy.
Prior to a large scale screen was started the optimal conditions were established. A general 
problem of the L40 strain is the leakiness of the HIS3 marker. It can happen for some reporter 
strains that the HIS3 gene is transcribed at a very low level even without activation of the reporter 
genes, thus some colonies can appear on selective plates lacking histidine increasing the number 
of false-positives. To circumvent the problem of a high background, 3-Amino-1,2,4-triazole (3-
AT) can be added to the selective plates. As competitive inhibitor of the HIS3 protein (His3p), 3-
AT is a commonly used reagent supplied to selective plates in YTH screens, in order to inhibit low 
levels of His3p expressed in a leaky manner in some reporter strains (Bartel et al., 1993; Durfee 
et al., 1993). The concentration of 3-AT was determined for each library (typeI and typeII) by 
titrating the concentration from 40mM down to 0mM. The best concentration was elicited at 
5mM for both libraries. In a second step the transformation efficiency was determined (5x104-
105 /µg library DNA). Then we decided in a first attempt, to screen only the library for type I 
transmembrane proteins since the library for tape II transmembrane proteins gave an enormous 
amount of unspecific interactors (personal communication with I. Stagljar). Finally 6x106 colonies 
Clone number Blast hit, description 
A004 Mus musculus RIKEN cDNA 5830471E12 gene 
A007 Mus musculus platelet derived growth factor receptor (PDGFR)
A032 Mus musculus E1B 19K/Bcl-2-binding protein
A040 No hit, unknown 
A043 Mus musculus nuclear receptor co-repressor 1 
A044 Mus musculus mRNA for beta-sarcoglycan 
A056 Mus musculus eukaryotic translation elongation factor 
A069 Mus musculus glycosylphosphatidylinositol-l... 
A092 Mus musculus RIKEN cDNA 2810411G23 gene 
A116 Mus musculus expressed sequence C81457 (C81457) 
A120 Mus musculus EAAT3 glutamate transporter regulator 
A139 Mus musculus DnaJ (Hsp40) homolog, subfamily A,...  
A165 Mus musculus, Similar to cytochrome c oxi 
A178 Mus musculus fibronectin 1 (Fn1), mRNA  
A184 Human c-erb-B-2 mRNA 
A185 Human DNA sequence from clone RP11-472K8 on chro...  
A187 Mus musculus similar to glycogenin-interacting 
A201 Mus musculus actin, alpha 1, skeletal muscle  
A202 Mus musculus mel-13a transcript 
A220 Mus musculus muscle glycogen phosphorylase  
A221 Mus musculus actin, alpha 1, skeletal muscle 
A228 Mus musculus feminization 1 homolog a 
A232 Homo sapiens cDNA FLJ14006 fis, clone Y79AA10023 
A238 Mus musculus plakophilin 1 (Pkp1), mRNA 
Table 2.2 | Sequence analysis of the candidates that were found to be positive in the 1st screen
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from the typeI library were screened. 238 colonies survived on selective plates (-LTUH) supplied 
with 5mM 3-AT and also turned blue in the test for ß-Galactosidase (ß-Gal) activity.
In order to get to fast results, the library plasmids were recovered from each positive colony 
and sequenced. 211 of all clones turned out to be false positives. Most of them (90%) encoded for 
ubiquitin and 10% for cytochrome C. Only 24 clones or 11% of all sequenced clones, shown in 
table 2.2, ended up to be putative candidates as MuSK interactors.
2.4.4 Analysis of the candidates
Closer analysis of the candidates showed that some of them were transmembrane (TM) pro-
teins and some were specifically expressed at the NMJ (Table 2.2). To confirm the hits, we next 
performed bait-dependency tests. The bait-dependency test demonstrates the dependence of the 
activation of the reporter system from a given bait. In addition, the sequence has to be analyzed to 
make sure the coding sequence of the candidate is in-frame with the NubG reporter. In a first bait 
dependency test, none of the candidates resulted to be positive. Therefore, another screening round 
was performed for typeI as well as for typeII transmembrane proteins. For type I transmembrane 
protein 107 colonies and for type II transmembrane proteins 3x106 colonies were screened. 
The type I library screen resulted in 1042 colonies growing on selective medium that were 
picked and patched again on selective plates. 19% were false positives and did not regrow. All the 
844 remaining clones showed ß-Gal activity, and were considered as putative candidate. In the 
first screen we experienced a high amount of false positives to be ubiquitin. Hence, an analytical 
PCR was designed in order to specifically discard all false positive clones containing ubiquitin. 
Thus from the remaining 844 clones another 81% could be eliminated. Moreover, the remaining 
164 clones were subjected to restriction digestion analysis. Finally, from all 164 plasmids only 63 
carried an insert. Thus, almost 95% of all clones were false positives and could be discarded, re-
sulting in 63 candidates, which were then subjected to bait dependency tests.
With 1011 picked colonies, almost the same number of positive clones were patched for the ty-
peII library screen. But in contrast to the type I screen, only the large and the medium sized colo-
nies, which were the minority of all colonies, were taken for re-growth and for analysis for ß-Gal 
activity. Unexpectedly, all colonies re-grew on selective medium in this case. While a consistent 
difference in ß-Gal activity is usually observed, all clones showed an overall similar behavior and 
turned blue within 2h. Compared to the type I screen where most of the false positive clones were 
found to be ubiquitin, sequence analysis of 20 randomly picked positive clones of type II screen 
gave a heterogeneous population of candidates. Since there is no big population of false positives, 
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as it was the case with ubiquitin in type I screen, false positives could not be easily discarded by 
application of an analytical PCR. Furthermore the large number of clones, more than 3000 (in-
cluding the small colonies) led us finally to discard all these candidates without further analysis.
Already during the first experiments a peculiar behavior of the L40wt reporter strain was noted. 
These observations were confirmed after the bait dependency test for the first 25 candidates was 
done. Beside that none of the candidates passed the bait dependency test, not even the control 
prey Ost1, which was shown to interact with Wbp1 (Stagljar 1998) activated the reporter genes. 
Together with the observations that L40wt strain (a) grows very slowly in liquid media and on 
plates, (b) has a long recovery time after entering stationary phase, (c) has heterogeneous colony 
size on plates, (d) possesses a high variation in transformation efficiency, and (e) aggregates in 
liquid culture, we concluded that the L40wt reporter strain could be genetically instable or could 
carry second-site mutations that affect its performance. One possibility for this instability is that 
further expression of the strain led to mutations.
Subsequently, to ensure accurate results, we therefore purchased the original strains from Rolf 
Sternglanz’s group. The reporter strains containing the bait and control bait were reconstructed. 
The newly constructed strains, MCY006 (TAT7 + pMuSK-Cub-PLV + C21B8-agrin) and MCY009 
(TAT7 + pWbp1p + C21B8-agrin), were subjected to tests for growth, tightness of the auxotrophy 
markers, transformation efficiency, and activation of the reporter genes by the control bait and 
prey. The new yeast strains showed a much improved reliability in all aspects and, most impor-
tantly, the controls for the bait dependency tests gave the expected results.
Finally, the obtained candidates could be tested for bait dependency in the new strains. How-
ever, the new strains gave the same response as the old strains as depicted in table 2.3. Except one, 
none of the tested candidates, 25 from the 1st screen and 63 from the 2nd screen for typeI TM-pro-
teins, activated the reporter genes. Moreover, the only positive clone could not be confirmed by 
repeating the bait dependency test. Since the screen was carried out with the old strain and the 
reporter gene assays in the new strain, we decided to repeat the screen for the third time using the 
new strain. In a first attempt  the screen was performed only for the typeI library. Only 55 clones 
grew out of 4x106 screened, which is compared to the number of candidates obtained until now a 
reasonable amount of clones. To confirm this promising result, the clones were subsequently ana-
lyzed on ubiquitin inserts by analytical PCR. Surprisingly, none of the clones contained ubiquitin. 
Since 55 clones can easily be handled, the plasmids were immediately recovered and tested on bait 
dependency. However again, all of the putative candidates failed to be responsive to the reporter 
genes.
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  ß-gal test survival test
colony# MCY006 MCY009 MCY006 MCY009
A 004 - - 0 3
A 007 - - 0 0
A 032 - - 0 0
A 040 - - 0 3
A 043 - - 0 0
A 044 - - 0 3
A 056 - - 0 0
A 069 - - 0 0
A 092 - - 0 0
A 116 - - 0 0
A 117 - - xx xx
A 120 - - 0 0
A 134 - - 0 3
A 139 - - 0 0
A 165 - - 0 0
A 178 - - 0 3
A 184 - - 0 0
A 185 - - 0 0
A 187 - - 0 0
A 201 - - 0 0
A 202 - - 0 0
A 220 - - 0 0
A 221 - - 0 0
A 228 - - 0 0
A 232 - - 0 0
A 238 - - 0 3
controls
A114 (only 2 patches)   0 2
OST 1  (only 2 patches)  0 2
pX_HA_NubG   0 0
D 001 0 0 0 0
D 002 2 2 2* 2
D 005 0 0 0 0
D 008 0 1 0 0
D 010 1 0 2 0
D 011 0 0 0 0
D 014 0 0 0 0
D 015  2 2 2* 2
D 017 2 2 2* 2
D 018 0 0 0 0
D 019 2 2 2* 2
D 022  0 0 0 0
D 025 0 0 0 0
D 026 2 2 2* 2
D 029 0 0 0 0
D 032 1 2 2* 2
D 033 0 1 0 0
D 035 1 0-1 0 0
D 036 0 0 0 0
D 037 1 1 0 0
D 040 2 2 2* 2
  ß-gal test survival test
colony# MCY006 MCY009 MCY006 MCY009
D 042 2 2 2* 2
D 044 0 0 0 0
D 046 0 0 0 0
D 047 0 1 0 0
D 049 0 1 0 0
D 050 0 1 0 0
D 051 1 2 0 2
D 052 0 1 0 0
D 053 0 1 0 0
D 062 2 2 2* 2
D 064 2 2 2* 2
D 068 1 2 1* 2
D 070 1 2 0 2
D 074 0 0 0 0
D 076 1 2 0 2
D 078 0 0 0 0
D 082 2 2 2* 2
D 084 0 0 0 0
D 087 0 0 2 2
D 093 0 1 0 2*
D 094 2 2 2 2*
D 095 2 2 0 2
D 097 0 1 2 2
D 099 0 1 2 2
D 102 1 1 0 0
D 105 1 1 0 0
D 106 0 0 0 0
D 111 1 1 0 0
D 112 0 1 0 0
D 119 1 0-1 0 0
D 122 2 2 0 2
D 123 1 1 0 0
D 124 1 1 0 0
D 125 2 2 2* 2
D 127 1 2 0 2
D 133 2 2 0 2
D 137 1 2 0 2
D 138 2 2 1* 2
D 139 0 2 0 2
D 146 0 1 0 0
D 151 0 0 2 2
D 153 1 1 2 2
controls
sss1 2 2 0** 2
MuSK 0 1 0 0
pX-HA-NubG 0 2 0 2**
Table 2.3 | Bait dependency test of candidates that came up in screen I & II of type I library 
All clones numbered with A are candidates from the 1st screen and clones from the 2nd screen were labeled with D. The ß-Gal test was per-
formed only for candidates of the 2nd screen. Three patches of each clone were tested for ß-Gal activity, whereas the colonies were left to react 
for ~6h hours. Code for ß-Gal test: 0:  no color; 1: light blue color; 2: all colonies have strong blue color. The survival test was performed on three 
randomly picked colonies, which were grown on plates containing histidine (His) and immediately re-streaked on selective plates lacking His. 
Plates were analyzed for growth after 2-3 days. Code for survival test: 0: no growth; 1: different growth of the 3 clones; 2: normal growth of 
all three clones; *: weak growth; **: revertants came up. Abbreviations: MCY006: L40 strain expressing pMuSK-Cub-PLV and LG3B8-agrin - test 
bait; MCY009: L40 reporter strain expressing pWbp1 and LG3B8-agrin - control bait; A114: clone found in the first screen, containing ubiquitin 
- positive control; OST1:  known interaction partner of Wbp1 - positive control; MuSK: MuSK containing prey - negative control; sss1:  known 
interaction partner of Wbp1 - positive control.
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2.4.5 New controls to verify the mYTH system
It was shown that Src and fyn, two tyrosine kinases belonging to the family of Src-kinases are 
associated with MuSK (Mohamed et al., 2001). Furthermore, while the screening was on its way 
the group of Lin Mei published one paper where they describe Dvl1 to be a novel interacting part-
ner of MuSK (Luo et al 2002). In the meantime, the same group identified an additional MuSK 
interactor, geranylgeranyltransferase I (GGT; Luo et al., 2003). Both, Dvl1 and GGT were identi-
fied using a nuclear YTH-system with the MuSK-intracellular domain as bait.
Since the mYTH-system is designed to also trap intracellular interactors, we thought to test our 
system using these interactors. This was done by using a prey containing dvl1 and a fragment of 
dvl1, dvl1∆DIX that was found by Luo and colleagues (2002) to strongly interact with MuSK. To 
avoid the reporter to obstruct dvl1 in the interaction with MuSK, two constructs were generated 
for each of dvl1 and dvl1∆DIX where NubG was placed either at the C-terminus or the N-termi-
nus. Subsequently, the new preys were tested for activation in the MuSK-bait expressing reporter 
strain. Again, dishevelled was not able to activate the reporter genes, even though we could show 
by western blot analysis that dvl1 constructs are abundantly and correctly expressed in yeast.
Because, none of the candidates could be confirmed and because the Dvl1-prey failed to acti-
vate MuSK, we initiated a new series of experiments to analyze again the expression level of the 
bait pMuSK-Cub-PLV. Thus, the question arose why pMuSK-Cub-PLV could not be detected 
despite pMuSK-NubG was always shown to give a huge expression signal, even though the ex-
pression level between Wbp1 and truncated ADH promoter is only about 10 times higher. How 
can an interaction take place, if the bait cannot be detected? A solution to this problem would be 
to enhance the expression of the bait, but since changing the weak Wpb1 promoter to a stronger 
one would lead to self-activation we landed in a dead end. Luckily, Stagljar and colleagues expe-
rienced the same problems, whereas we got a set of new plasmids they have constructed, contain-
ing a stronger expression level (pCMBV, pAMBV, pTMBV). But in order to avoid selfactivation 
a mutation was introduced in the DNA binding domain LexA. This mutation resulted in a lower 
binding affinity of LexA to its operon, hence the expression level could be increased without acti-
vating the reporter genes.
All the new vectors were non-integration vectors but single copy episomal CEN/ARS-vectors. 
In the new vectors the protein A tag was replaced by an HA-Tag which has the advantage that it is 
much smaller than protein A. Additionally, these plasmids contained either CYC1, ADH or TEF-
promoter, that are approximately 2-, 4- or 10-fold stronger that Wbp1 respectively. Thereafter, a 
new bait under the control of the TEF promoter was constructed. But also with the strongest avail-
able promoter, no protein could be seen by Western blot analysis. Contradictory, Wbp1, which 
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was also cloned into the bait plasmid containing the TEF promoter showed a significant lower 
expression level compared to the previously used control Wbp1-bait under the Wbp1 promoter. 
Even after these results we did some more efforts in improving expression of MuSK in the bait 
plasmid, but without success. This was the point where we decided to stall the project, because we 
were not able to get reproducible results to show the expression of the bait.
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2.5 Discussion
The fact that not only dvl1 did not activate the reporter genes but that also none of the initially 
positive candidates could never be confirmed in the bait dependency test, raised even more doubts 
about the reliability of the system. Irreproducible results found in investigating expression of the 
bait were even more puzzling. By systematically analyzing the system several reasons were found 
that could explain the failing of the mYTH-system, (a) possible toxicity of the bait, (b) localiza-
tion of the bait, (c) expression level of the bait and (d) spatial arrangement of the two halves of 
ubiquitin.
2.5.1 Toxicity
In previous experiments we have demonstrated that overexpression of MuSK in HEK 293 cell 
leads to autophosphorylation of the  kinase (Fig 2.5 b). Receptor tyrosine kinases at the cell surface 
are best known to act as mediators for downstream signalling pathways, a process which is initi-
ated by transphorylation of the involved kinase. Autophosphorylation of MuSK could therefore 
erroneously lead to switch on some unrelated downstream events that result toxic to the yeast cell. 
Another possibility would be that MuSK is overexpressed in such a way that the yeast cell cannot 
handle this large amount of produced protein. Nevertheless, if this would be the case, transforma-
tion efficiency of MuSK would expected to be much lower, and general growth of yeast should be 
slow as well 
2.5.2 Protein localization
Although proper localization of the MuSK-bait could not been demonstrated by imunofluo-
rescence microscopy directly, several observation suggest that MuSK is correctly targeted to the 
membrane. For example expression of the bait alone does not result in any selfactivation. A wrong 
localization and therefore also a degradation of the bait would lead to the release of ‘PLV’, the 
reporter fused to MuSK. The released reporter would diffuse into the nucleus and activate the 
reporter gene for ß-Galactosidase. As this is not the case, it is highly likely that the MuSK-bait is 
localized to membranes in the yeast strain.
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2.5.3 Expression level
The expression level of the prey can immediately be excluded as reason for the failure of the 
screens, since all tested prey constructs showed a very strong expression, without causing any vis-
ible toxicity.
In contrast, the bait is a very critical parameter in the membrane-based split-ubiquitin YTH 
system. A very strong expression of the bait can lead to self activation of the system. However, if 
the expression is too low, the reporter system might not respond to its activation. Therefore an 
appropriate promoter has to be chosen. There was the choice between Wbp1, which is a weak 
promoter, or the stronger, truncated ADH promoter. In control experiments we could observe 
that pMuSK-Cub-PLV gives significant self-activation if expressed under the control of the trun-
cated ADH promoter. Therefore, the choice fell on the weaker Wbp1 promoter. Consequently, it 
was difficult to extract the bait and to show its expression by Western blot analysis, a fact, which 
persisted throughout all our experiments. We invested a lot of effort changing the expression level 
of the bait without causing self-activation of the reporter genes. Nevertheless, different expression 
systems were tested no considerable improve in expression was achieved. Since the improvement 
of the system per se was beyond our objectives, we finally decided to stall the project and wait until 
the system is matured to reach our goal.
2.5.4 Reconstitution of ubiquitin
Another disadvantage of the split-ubiquitin based YTH system is the probability of reassem-
bly of the carboxy- and the amino terminal halves of ubiquitin, since reconstitution of ubiquitin 
through an interaction between the bait and the prey is essential. The mYTH system is therefore 
much more susceptible to changes in three dimensional conformation of the interacting proteins 
compared to the nuclear YTH (nYTH). In the nYTH once the bait and the prey associate, the 
RNA polymerase starts transcription, irrespective of the spatial arrangement between bait and 
prey (reviewed in Brent and Finley, 1997). However, in the mYTH the place of interaction of bait 
and prey is very critical. If the interaction of the prey with the bait, which is always associated to 
the membrane, is for example very close to it or is at a place where the two halves of ubiquitin 
can never be assembled because of the rigid conformation of the involved proteins, ubiquitin 
can never be reconstituted. This hypothesis is supported by the fact that only the positive control 
gave an activation of the reporter genes, where constitutive active form of MuSK was used as bait 
and prey. Since the intracellular domains of the bait and the prey protein were the same in size 
and conformation, reassembly of the carboxy- and amino-terminal halves of ubiquitin was more 
likely. Thus, the addition of a long and flexible linker between the bait/prey and the two halves of 
ubiquitin respectively may be a substantial improvement of the system.
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2.6 Conclusions
The yeast two hybrid system is a powerful method for the identification of interaction partners 
for cytosolic proteins. Stagljar and colleagues successfully adapted the nuclear YTH system to a 
more sophisticated method which enables to study the interaction among membrane-associated 
proteins or membrane-associated and cytosolic proteins. Nevertheless, when we started the proj-
ect, the system was in a rather immature stage. From controls, protein expression to the construc-
tion of the cDNA library, many hurdles had to be taken during the whole work. Even though, 
many aspects could be improved, we finally came to a point, where we had to decide to stop the 
project and wait until the system has become more reliable.
Nevertheless, once this interesting technique becomes reliable it will be a powerful tool for 
large scale-screening of interactors of integral membrane proteins. The subsequent application of 
this novel method in the identification of interactions between postsynaptic proteins could lead 
to decisive findings to finally elucidate the mechanisms of postsynaptic assembly during develop-
ment.
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Site-directed mutagenesis of agrin splice inserts 
reveals amino acids involved in postsynaptic dif-
ferentiation at the neuromuscular junction
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3.1 Summary
Agrin, a basal lamina protein that is released from motor neurons, is required and sufficient 
for the formation of a stable neuromuscular junction. This activity resides in the carboxy-termi-
nal portion of the protein and is strongly modulated by alternative mRNA splicing. In particular, 
amino acid inserts are required at the B/z-splice site in the most C-terminal, laminin G-like (LG) 
domain. One of the essential components that mediates agrin’s effect is the muscle-specific recep-
tor tyrosine kinase MuSK. Indicative of MuSK activation, addition of agrin splice variants carry-
ing amino acid inserts at the B/z- site, induce phosphorylation of MuSK within minutes. 
Guided by the crystal structure of the LG domain derived from different agrin splice variants 
(Stetefeld et al., 2004), we set out to determine the contribution of single amino acids of the B/z site 
to agrin’s synaptogenic activity. Here we show that the amino acid motif Asn-Glu-Ile within the 
B/z splice site is conserved across all species and dispensable for activating MuSK. Significantly, 
the moving of some amino acids flanking the B/z exon to a more exposed site strongly contribute 
to agrin’s activity. Furthermore, we could show that α-dystroglycan (α-DG) has a role as auxiliary 
factor to concentrate agrin at the muscle surface and that the binding to α-DG is adjusted by in-
serts at A/y and B/z splice site of agrin. Finally, we propose a model where the splice inserts play 
a role in modulating the binding of agrin to α-DG and consequently affect the capability of agrin 
to activate MuSK.
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3.2 Introduction
Agrin is a heparansulfate proteoglycan best known for its function to induce and maintain 
postsynaptic specializations at the neuromuscular junction (NMJ).  Agrin-deficient mice are in-
capable of forming functional NMJs and lack postsynaptic specializations at birth (Gautam et al., 
1996; Lin et al., 2001).  Such mice also display aberrant presynaptic nerve terminals suggesting 
that proper formation of postsynaptic structures is requisite for presynaptic differentiation. As a 
consequence, agrin-deficient mice die at birth due to respiratory failure. Agrin alone is also suf-
ficient to induce postsynaptic structures when expressed in non-synaptic regions in adult, fully 
innervated muscle in vivo (Jones et al., 1997; Cohen et al., 1997; Meier et al., 1997). These data are 
strong evidence that agrin is both, required and sufficient to generate fully functional postsynaptic 
structures in skeletal muscle (reviews see Ruegg, 1998; Sanes, 2001). More recent evidence also 
suggests a role of agrin in the formation of the immunological synapse, synapses in the central 
nervous system (CNS) and the treatment of particular forms of muscular dystrophy (reviewed in 
Bezakova and Ruegg, 2003). 
The agrin gene undergoes alternative mRNA splicing at several locations giving rise to protein 
isoforms that differ in expression and function (Fig. 1 A). Alternative usage of exons at the 5’ end 
of the gene results in two different ways of attachment to cellular structures. The secreted form 
binds into basement membranes necessary to allow the formation of postsynapses in muscle (Bur-
gess et al., 2000). The second form encodes an internal, non-cleaved signal peptide that results in 
agrin being incorporated into plasma membranes as a type II transmembrane protein (Burgess et 
al., 2000; Neumann et al., 2001). The large distance (> 7 kb) between the exons encoding these two 
forms strongly suggests that they may also use different promoters. Support of this hypothesis is 
given by the fact that the expression of the two forms is cell specific. The secreted form is mainly 
expressed in non-neuronal cells and motor neurons of the spinal cord. Neurons in the brain ap-
pear to express the transmembrane version of agrin (Burgess et al., 2000; Neumann et al., 2001). 
Two additional splice inserts are located in the carboxy-terminal half of agrin and they are 
both localized within laminin G-like domains (LG). The insert within LG2, called A in chick and 
y in rodents, is encoded by a 12-bp long exon that encodes a heparin-binding site (Campanelli 
et al., 1996; Gesemann et al., 1996; Hopf et al., 1996). This insert is included in agrin transcripts 
expressed in neurons and glial cells while non-neuronal cells in the periphery, such as muscle, 
Schwann cells or kidney, lack this insert (Ruegg et al., 1992; Hoch et al., 1993; Stone et al., 1995). 
The second splice site, called B in chick and z in rodents, is encoded by two separate exons of 24 
bp and 33 bp length, respectively. Alternative splicing of these exons results in protein isoforms 
having 0, 8, 11 or 19 (8 + 11) amino acids inserts at the B/z-site. Splicing at the B/z-site influences 
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agrin’s function to induce postsynaptic structures at the developing NMJ. Like mice deficient in 
the entire agrin protein, mice in which the two exons encoding the B/z-site were deleted and thus 
express only agrin isoforms that lack any amino acid inserts at this site fail to form functional 
NMJs (Burgess et al., 1999). 
The activity of agrin to induce postsynaptic specializations at the NMJ can be reproduced in 
vitro using cultured myotubes. In this assay, the presence of amino acid inserts at the B/z-site is 
also necessary to induce the aggregation of acetylcholine receptors (AChRs; Ruegg et al., 1992; 
Ferns et al., 1993; Gesemann et al., 1995). The AChR-aggregating activity of agrin requires the 
muscle-specific receptor tyrosine kinase MuSK. MuSK-deficient mice show the same phenotype 
as agrin mutants (DeChiara et al., 1996) although recombinant MuSK does not directly bind to 
agrin (Glass et al., 1996). Nevertheless, its phosphorylation correlates well with the AChR-aggre-
gating activity of agrin isoforms. For example, agrin B/z-0 isoforms, which lack AChR-aggregating 
activity do not induce MuSK phosphorylation, while agrin isoforms with high AChR-aggregating 
activity are able to activate MuSK at low concentrations (Glass et al., 1996). These data thus indi-
cate that MuSK is an essential component in an agrin receptor complex and that phosphorylation 
directly correlates with AChR aggregation activity of agrin isoforms.
Another function that involves the LG domains of agrin is the binding to α-dystroglycan, a 
peripheral membrane protein expressed in many tissues including muscle. α-DG arises from the 
precursor protein dystroglycan by posttranslational cleavage (Ibraghimov-Beskrovnaya et al., 
1992). Besides agrin, α-DG binds to the LG domains of several laminin isoforms, perlecan and 
neurexins (reviewed in Winder, 2001). Although initially postulated, binding of agrin to α-DG 
is not necessary for its AChR-aggregating activity (Gesemann et al., 1996). The binding of agrin 
to α-DG is also regulated by alternative mRNA splicing at sites A/y and B/z because a carboxy-
terminal fragment that includes amino acid inserts at both sites (agrin A/y-4, B/z-8) binds to a-
dystroglycan with several fold lower affinity than the corresponding fragment lacking amino acid 
inserts (i.e. agrin A/y-0, B/z-0). In summary, these results indicate that splicing at sites A/y and 
B/z influence the biological activity of agrin strongly. 
Recent structural analysis of different variants of LG3 has led to new insights of how agrin 
may exert its AChR-aggregating activity and its binding to α-DG.  The main results were that (1) 
the overall fold of the LG3 domain is very similar to that of LG domains in neurexin (Rudenko 
et al., 1999), laminin-1 (Hohenester et al., 1999) and Gas6 (Sasaki et al., 2002), (2) the B/z splice 
insert is highly flexible indicative of an “induced-fit” mechanism of docking to its putative recep-
tor. (3) The structure of different splice forms of the LG3 domain diverge already 7 amino acids 
before and 6 amino acids after the inserts. (4) Depletion of Ca2+ from LG3B/z-8 induces structural 
changes at the same amino acids where the different protein isoforms diverge. 
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Here, we studied the influence of individual amino acids on agrin’s function. We find that 
mutations in B/z-NB8A and B/z-EB8A of the B/z-8 site in LG3 attenuates the capability to induce 
phosphorylation by ~100 fold.  Surprisingly, mutations of all eight amino acids to alanine did not 
further lower its activity and MuSK phosphorylation was still much higher than that of the agrin 
splice variant lacking any amino acid inserts at the B/z-site.  Together with the result that, in con-
trast to the insert at the A/y-site, mutations in the B/z-site do not affect α-dystroglycan binding, 
we present a model whereby amino acids outside of the B/z-site strongly contribute to agrin’s 
function in activating a MuSK receptor complex. 
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3.3 Material and Methods
Antibodies
Polyclonal antisera 194T against the extracellular domain of MuSK (MuSK-ECD) was raised in 
rabbits by injecting a His-tagged MuSK-ECD, purified from supernatants of transfected HEK293 
EBNA cells. For the first injection ~60µg of protein in complete Freund’s adjuvant was used. 
Specificity of anti-MuSK-ECD IgG was determined by staining cryostat-sections of embryonic 
day 18 mouse soleus muscle and Western blot analysis.
Cell Culture and Transfections
Myotubes from the mouse cell line C2C12 were prepared as previously described (Gesemann 
et al., 1995). Human embryonic kidney cells, which constitutively express the EBNA-1 protein 
from Epstein-Barr virus (293 EBNA, Invitrogen) were cultured in DMEM supplemented with 
10% fetal calf serum (PAA), 10 mM sodium pyruvate, 100 U/ml penicillin and 100µg/ml strepto-
mycin. 293 EBNA cells were transiently transfected with the agrin expression constructs using the 
JetPei transfection reagent (QBiogene). After 2-7 days the conditioned medium was collected and 
the concentration of the recombinant agrin protein was determined as described below. Addition-
ally, the proteins were visualized by Western blot analysis (supplementary Fig. 1).
 
AChR Aggregation Assay
Approximately 4x 105 C2C12 cells were seeded on gelatin-coated, 35mm tissue culture dishes 
(Falcon) and after one day, medium was replaced with DMEM supplemented with 5% horse se-
rum, 10 mM sodium pyruvate, 100 U/ml penicillin and 100µg/ml streptomycin. After 4-6 d, cells 
had fused and AChR aggregation assays were performed. The myotubes were incubated with 
recombinant agrin proteins for ~16 h at 37°C. Thereafter the cells were incubated in the same 
medium containing 1µg/ml rhodamine-α-bugarotoxin (Molecular Probes, Eugene, OR) for 45-60 
min at 37°C. Cells were washed three times with prewarmed PBS, fixed for 10 min in 2% PFA. Af-
ter washing the cells were mounted on glass coverslips with cityfluor (Plano) and examined with 
a microscope equipped with epifluorescence (Leica, Nussloch, Germany).
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Expression Constructs
wt-proteins: The constructs pc95A4B8, pc95A0B0 (Gesemann et al., 1995) and phumanγ1 
(F. Oliveri) were used as PCR-templates to generate the cDNA construct encoding C45A4B8-
agrin, C45A0B0-agrin fused to a human γ1 Fc tag. Primers used to amplify the fragments for 
C45A4B8-agrin and C45A0B0–agrin were s4655_NheI, 5’  CGAAGCTCAGTGAGCAGGAC-
CACACCATG 3’ and as6227_BamHI, 5’ CACGAGGATCCCTTTGGCTGATCAGTGTAATA 
3’ and primers used for the amplification of the humanγ1-Fc-tag were shγ1_BamHI, 5’ TGAG-
GATCCTAGAGCCCAAATCTTCTGAC 3’ and ashγ1_XhoI, 5’ GCTGACTCGAGTCATT-
TACCCGGAGACAGGGAGAG 3’. The PCR products were cloned in-frame to the BM-40 signal 
peptide (Kohfeldt et al., 1997) into the expression vector pCEP-Pu opened with XhoI and NheI. 
This vector included the BM-40 UTR (including a Kozak sequence), the BM-40 signal peptide for 
proper secretion into the culture medium. The C45A4B0-humanγ1-Fc construct was generated by 
digesting C45A4B8-humanγ1-Fc with HindIII/XhoI and ligating the fragment containing the A4-
insert into C45A0B0-humanγ1-Fc opened with HindIII/XhoI. Similarly the C45A0B8-humanγ1-Fc 
construct was generated by digesting C45A0B0-humanγ1-Fc with BamHI/XhoI and ligating the 
fragment containing the B0-insert into C45A4B8-humanγ1-Fc opened with BamHI/XhoI.
Mutant proteins were generated by site-directed mutagenesis using pbluescript KS+ vector 
(Stratagene) containing the C45A4B8-agrin fragment as template. Mutations were introduced by 
designing forward and reverse primers with overlapping 5’ ends and encoding sequences on ei-
ther side of the mutation (primer sequences are available on request). PCR was performed by 
amplifying the whole plasmid with long expand polymerase kit (Roche Diagnostics). Thereafter, 
the template was removed by DpnI digestion and the new plasmid containing the mutation was 
transformed into DH10B chemically competent cells. After confirmation of the sequences by dye 
terminator cycle sequencing ready reaction kit (ABI), the mutated C45A4B8-agrin fragments were 
subcloned into BamHI/EcoRI opened pCEP-Pu vector containing BM-40 and humanγ1-Fc tag.
Quantification of Agrin-Protein
To quantify recombinant agrin proteins, 100µl goat anti-humanγ1 IgG (1µg/ml, Novocas-
tra)  in 50 mM sodium carbonate buffer (pH 9.6) was immobilized on a 96-well high-binding 
microtiter plate (Costar) followed by incubation of agrin proteins at a concentration between 0.1 
and 100 ng/ml. As a secondary antibody, a HRP-conjugated goat anti-human γ1 IgG was used in 
a 1:10,000 dilution. As internal standard, affinity-purified recombinant C45A4B8 agrin of known 
concentration was used. Immunoreactivity was measured by using McEvans solution, ABTS and 
H
2
O
2
 as an HRP-substrate. The absorbance was measured on an ELISA-reader at 405 nm.
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Solid Phase MuSK Phosphorylation Assay
C2C12 myoblast were grown on gelatin-coated 96 well Microtest plates (falcon) as previously 
described (Gesemann et al., 1995). The differentiated C2C12 myotubes were stimulated 30min 
with different dilutions of agrin wild-type- and mutant-proteins in phosphate buffer, pH 7.4 sup-
plemented with 5.6 mM Glucose, 137 mM NaCl, 1 mM MgCl
2
, 1.25 mM CaCl
2
, 25mM HEPES and 
1mg/ml BSA. The stimulated proteins were extracted in lysis buffer (20mM HEPES, 1mM EDTA, 
1mM EGTA, 150 mM NaCl, 1% Nonidet P40, phosphatase inhibitors and protease inhibitors) 
for 30 min at 4°C. The extracted proteins were transferred and incubated for 5h at 4°C to a 96-
well high-binding microtiter plate (Costar), which was previously coated overnight at 4°C, with 
100µl/well of anti-phosphotyrosine antibody 4G10 (1µg/ml, Upstate) in 50 mM sodium carbonate 
buffer pH 9.6 and blocked in PBS containing 0.5% Tween-20 and Top Block (Juro). The extracts 
were removed and the microtiter plate was washed with PBS containing 0.1% Tween 20 (PBST). 
Thereafter the microtiter plate was incubated overnight at 4°C with 100µl/well of affinity purified 
194T primary antibody against MuSK (1:5000) in PBS containing 0.1% Tween 20 and 0.1% Top 
Block (incubation buffer). The plate was rinsed 4 times with PBST and incubated 4h at 4°C with 
100µl/well of an HRP-conjugated donkey anti-rabbit IgG secondary antibody in incubation buf-
fer. Subsequently, the plate was washed with PBST four times and once with PBS. For detection 
of the immunoreactivity the HRP substrate solution QuantaBlue (Pierce) was mixed according 
to the manufacturer and 100µl were added into each well. After incubation at RT for 30 min the 
reaction was stopped by adding 100µl/well of QuantaBlue stop solution. The fluorescence was 
measured on an ELISA reader (Gemini) at 420nm after excitation at a wavelength of 325 nm. 
Purification of α-Dystroglycan 
10g of frozen chicken breast were homogenized in 40ml of 50mM Tris/HCl pH 7.4 containing 
0.2 M NaCl (buffer A). After centrifugation (12’000g) the supernatant was filtered using a What-
man filter paper. The solution was incubated with 10ml of DEAE-Sephacel beads (Pharmacia-Am-
ersham) equilibrated with buffer A, at 4°C. After extensive washing with buffer A, bound proteins 
were eluted in 50mM Tris/HCl pH 7.4 and 0.5 M NaCl (buffer B). The eluate was subsequently 
incubated with 5ml in buffer B equilibrated WGA-sepharose. After washing the resin 5 times with 
buffer B elution from WGA-sepharose was achieved by adding 300mM N-acetylglucosamine. 
Eluted proteins were then dialyzed against 150mM NaCl, 10mM Tris-HCl pH 7.4. The purity of 
α-dystroglycan was verified on transfer overlay binding assay as subsequently described. 
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Solid Phase α-dystroglycan Binding Assay 
Enzyme-linked binding assays were performed with 100µl of α-dystroglycan (5µg/ml) in 50 
mM sodium carbonate buffer pH 9.6, immobilized on a 96-well high-binding microtiter plate (Co-
star) by absorption overnight at 4°C. After blocking with PBS containing 0.05% Tween-20, 1mM 
CaCl
2
, 1mM MgCl
2
 and 3% BSA (blocking buffer) wells were incubated with different dilutions of 
agrin wild-type- and mutant-constructs in blocking buffer. The wells were washed with blocking 
buffer and incubated with a HRP-conjugated goat anti-human-γ1 IgG in a 1:10,000 dilution. The 
color was developed using McEvans solution and ABTS/H
2
O
2
 as substrate. The absorbance was 
measured on an ELISA-reader at 405nm. To avoid saturation of the signal, measurements were 
performed every 5min.
Transfer Overlay Binding Assay
Purified chicken skeletal muscle α-dystroglycan was treated with reducing SDS sample buffer, 
separated by 3-12% gradient SDS-PAGE (Laemmli, 1970), and transferred to nitrocellulose (Tow-
bin et al., 1979). Blots were blocked for 2h with PBS containing 0.05% Tween-20, 1mM CaCl
2
, 
1mM MgCl
2
 and 5% dry milk powder (blocking buffer). The membrane was cut in strips and 
subsequently incubated overnight at 4° with different recombinant agrin proteins in blocking buf-
fer. Thereafter the nitrocellulose membrane strips were washed 3 times with blocking buffer and 
agrin immunoreactivity was detected by incubating the blots for 2h with a horse radish peroxi-
dase-conjugated goat anti-human-γ1 IgG (1µg/ml, Novocastra) at a dilution of 1:10,000. Finally 
the membrane strips were washed three times with blocking buffer and once with PBS containing 
0.05% Tween-20, 1mM CaCl
2
 and 1mM MgCl
2
. Immunoreactive protein bands were then visual-
ized by the ECL detection method (Pierce).
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3.4 Results
3.4.1 Constructs and cellular assays
As previously shown, binding to α-dystroglycan and AChR aggregation can be separated by 
generating a deletion construct that comprises only the LG3 domain (Gesemann et al., 1996; Cor-
nish et al., 1999).  This single LG domain does not bind to α-dystroglycan but is still active in 
AChR aggregation assays although with ~100-fold lower potency. To allow direct comparison 
of α-dystroglycan binding and AChR-aggregating activity of recombinant agrin, we used frag-
ments encompassing the two carboxy-terminal LG modules separated by one epidermal growth 
factor (EGF)-like repeat (Fig. 3.1B). For detection and purification of the recombinant proteins, 
the γ1 chain of human IgG was fused in-frame to the carboxy-terminal end. Recombinant pro-
tein was generated as described elsewhere (Eusebio et al., 2003) using HEK293 EBNA cells. As a 
readout for agrin’s activity to induce postsynaptic differentiation, we additionally established a 
two-side enzyme-linked immunosorbent assay (ELISA; Fig. 3.1 C) that allows measuring MuSK 
phosphorylation induced in cultured C2C12 myotubes by the use of an antiserum raised against 
the extracellular region of mouse MuSK. As shown in Figure 3.1 D, the assay was able to detect 
MuSK phosphorylation upon stimulation with neural agrin, while no signal above background 
could be detected in non-treated myotubes and myoblasts treated with neural agrin. The back-
ground signal originated mainly from binding of the anti-MuSK antiserum to the coated 4G10 
antibody (data not shown) which might be due to tyrosine phosphorylation of some of the IgG. 
Together, these results confirm the specificity of the two-side ELISA to measure phosphorylation 
of MuSK in cultured C2C12 cells, therefore we decided to use this assay in evaluating the contri-
bution of individual amino acids for agrin’s MuSK phosphorylation activity.
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Figure 3.1 | Structure of chick agrin, used constructs and 
proof of principle of the phospho-ELISA
(A) Schematic representation of full length chick agrin show-
ing its structural domains, sites for potential N-glycosylation 
and glycosaminoglycan side chain attachment, and location 
of splice sites A and B including amino acid sequence. SS, 
signal sequence; NtA, amino terminal agrin domain; TM, 
transmembrane segment; FS, follistatin-like domain; LE, 
laminin EGF-like domain; S/T, serine/threonine rich region; 
SEA, sperm protein, enterokinase and agrin domain; EG, epi-
dermal growth factor domain; LG, laminin globular like do-
main. (B) C45A0/4B0/8-hγ1-Fc construct is composed of the last 
two LG domains separated by an EG domain. It is preceeded 
by the signal sequence from BM40 and followed by Fc re-
gion of hγ1. LG2-hγ1-Fc and LG3-hγ1-Fc were constructed 
analogously. BM40: signal sequence; hγ1-Fc: Fc part of hγ1 
IgG. (C) Cartoon showing the principle of the solid phase 
phospho-ELISA in one well, to measure the phosphorylation 
state of MuSK in cultured C2C12 cells in 96-well plate for-
mat. The tyrosine phosphorylation assay is divided in 5 steps: 
1. Coating with Mouse anti-phospho-tyrosine IgG 2. C2C12-
cell extract 3. Rabbit anti-MuSK IgG (194T) 4. Donkey anti-
rabbit HRP-conjugated IgG 5. HRP - fluorescent substrate 
(D) MuSK phosphorylation measured from myotubes (MT) 
activated by agrin (MT + agrin), myotubes without agrin 
(MT), and myoblasts incubated with agrin (MB + agrin). As 
negative control phosphorylation was measured without 
cell extract, without addition of primary antibody (194T) 
and without coating (n>5, ***P<0.0001 in two-tailed t test. 
Bars +/- SEM).
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3.4.2 Amino acids within the B/z site important for agrin-MuSK 
phosphorylation
The previous results have shown that amino-acid inserts at the B/z site are essential for agrin-
induced AChR clustering (Gesemann et al., 1995; Ferns et al., 1992) and MuSK phosphorylation 
(Glass et al., 1996; Hopf and Hoch, 1998). As shown in Figure 3.2 A, 5 out of the 8 amino acids 
B/z are identical between species and amino acid sequence flanking the B/z site is also highly 
conserved. In a first series of experiments, we compared MuSK phosphorylation activity of agrin 
splice variants lacking amino acids at the B/z site with a construct where all 8 amino acids were 
mutated to alanine (construct C45B8-A8). While the neural form of agrin (construct C45A4B8) 
exerted high MuSK phosphorylation activity, both isoforms lacking amino acids at the B/z site 
(C45A4B0, C45A0B0) were inactive in this assay. Mutation of all 8 amino acids (B8-8A) shifted the 
potency by approximately 100-fold (Fig. 3.2 C; Table 3.1). Interestingly, however, this mutant was 
still more active than the agrin isoforms lacking any amino acids at the B/z site. Thus, beside ami-
no-acid side chains within the B/z site, there must be additional residues outside of this splice site 
that contribute to MuSK phosphorylation activity of agrin. Consistent with this, peptides com-
A B
C D
Mouse agrin : 1778 L N A V T E S E L T N E I P A E K A L Q S N 1791
Rat agrin : 1778 L N A V I E S E L T N E I P A E K A L Q S N 1791
Human agrin : 1778 L N A V T E S E L A N E I P V E K A L Q S N 1791
Omata agrin : 1778 H N T V T R S H L A N E I P D E K A V Q V N 1791
Chick agrin : 1778 H N A V T K S H L S N E I P A E K A L Q S N 1791
conserved aa : 1778 - N - V - - S - L - N E I P - E K A - Q - N 1791
B/z Splice: 8aa insert
C45A4B8 : H L S N E I P A
C45-B8-8A : A A A A A A A A
C45-NB8A : H L S A E I P A
C45-EB8A : H L S N A I P A
C45-IB8A : H L S N E A P A
C45-NEIB8AAI : H L S A A I P A
C45-NEIB8AES : H L S A E S P A
C45-NEIB8AAA : H L S A A A P A
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Figure 3.2 | Sequence comparison of agrin within the B/z exon and dose response curves of MuSK phosphorylation induced by recombinant 
agrin carrying mutations within the B/z splice site.
(A) Comparison of agrin sequence between species reveals 5 conserved amino acids within the B/z splice site, 3 immediately before and 5 
just after the B/z exon. (B) Mutations generated within the 8 amino acids of the B/z exon of C45A4B8 construct. (C) Comparison of MuSK 
phosphorylation between isoforms of muscle agrin (C45A0B0, C45A4B0) and neural agrin (C45A4B8). Dose response curves show that insertion of 
the 8 amino acids long exon within B/z splice site is indispensable to phosphorylate MuSK. Mutation of all 8 amino acids within the B/z splice 
site show significant 100-fold reduction of potency. (D) Single mutants within the B/z splice site show no significant effect on MuSK activa-
tion. Double mutation C45NEIB8AAI within the NEI motif shows a shift of EC50MuSK from 32pM to 874pM. The triple mutation C45NEIB8AAI show 
a decrease in potency similar to C45B8-A8. 100% was set for maximum phophorylation level of C45A4B8 agrin. Each data point represents mean 
+/- SEM of at least 4 replicates.
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prising the 8 aa insert or a multimer of such peptide 
does not induce nor inhibit MuSK phosphorylation 
(data not shown).
In a next step, we aimed at determining the critical 
amino acids within the B/z site. To this end, each con-
served amino-acid within the B/z site (see Fig. 3.2 A and 
B) was mutated to alanine and MuSK phosphorylation 
was measured. All of these single mutants had the 
same potency as C45A4B8 (not all mutants are shown, 
Fig. 3.2 D; Table 3.1). We therefore made double and 
triple mutants and evaluated their activity. As shown 
in Figure 3.2D, the triple mutant C45NEIB8AAA and 
the double mutant C45NEIB8AES exerted a similarly 
low potency as the C45B8-8A mutant. The double mu-
tant C45NEIB8AAI had an activity that was between 
 EC50 [pM] SEM [pM] 
 32.17 +/- 4.4
 n/d
 n/d
 8.72 +/- 1.1
 3432.50 +/- 746.8
 14.80 +/- 3.9
 27.06 +/- 4.5 
 24.66 +/- 3.6
 14.58 +/- 2.2
 874.17 +/- 146.7
 2598.20 +/- 498.5
 2430.20 +/- 1024.4
 19.28 +/- 2.8
 0.53 +/- 0.01
 38.06 +/- 3.8
 0.55 +/- 0.26
 22.87 +/- 3.9
 55.48 +/- 8.8
 15.29 +/- 3.0
C45-A4B8
C45-A0B0
 C45-A4B0
 C45-A0B8
C45-B8-8A
C45-HB8A
C45-NB8A
C45-EB8A
C45-IB8A
C45-NEIB8AAI
C45-NEIB8AES
C45-NEIB8AAA
C45-V1781A
C45-N1779A
C45-N1791A
C45-N1779A/N1791A
C45-E1785A
C45-K1786A
C45-H1778A
C45A4B8 and the C45B8-8A mutant. Concomitant with the loss in potency, we also observed a 
decrease in efficacy (Fig. 3.2 D). Moreover, the construct C45HLSNEIPAB8AAANEIAA, where only 
the NEI motif is maintained, shared a similar activity as C45A4B8 (Fig 3.2 D). Thus, we suggest 
that side chains derived from the NEI tripeptide within the B/z-8 exon are the only determinants 
of agrin’s activity.
3.4.3 Amino acids surrounding the B/z splice site do not show 
significant change in MuSK activation
Because mutation of all amino acids within the B/z site did not result in a complete loss of activ-
ity, we decided to mutate amino acid residues in the region flanking the B/z site. 
Beside comparison of amino acid sequence across different species the residues to mutate were 
selected based on the 3 dimensional structure of LG3 domain of agrin (Stetefeld et al. 2004). The 
main difference between the structures of the inactive B/z-0 form and the active B/z-8/11 neural 
isoforms extend from His1778 to Ser1790 (Fig 3.2 A), which encompass the splice site. This led us 
to speculate that amino acid at His1778, Asn1779 and Asn1790, which reside exactly  at the point 
of divergence of the two structures may contribute to agrin’s activities. The same region was also 
reported to show the largest change by binding of Ca2+ (Stetefeld et al., 2004).
Furthermore, residue Glu1785 is demonstrated to be involved in indirect coordination of Ca2+ 
through water bridges (Stetefeld et al., 2004). Moreover, Ca2+ coordination by Glu1785 is further 
stabilized by the neighboring amino acid Leu1786. According to this data and previous studies 
Table 3.1 | Summary of EC50s for MuSK phosphoryla-
tions measured upon activation with wild-type and 
mutant agrin
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where it was shown that clustering activity of agrin is Ca2+ dependent (Campanelli et al., 1996; 
Borges et al., 2002; Megeath and Fallon, 1998), we additionally mutated Glu1785 and Lys1786 
to Ala (Fig. 3.3 A). None of these single mutants affected agrin’s MuSK phosphorylation activity 
(Fig. 3.3 B). Thus, coordination of Ca2+ seemed to be compensated by other residues since neither 
Glu1785- nor Lys1786-mutant did affect agrin’s activity. The only exceptions were mutation of 
Asn1779 to Gly and the double mutant Asn1779Gly/Asn1791Gly, which resulted in approximate-
ly 50-fold increase in potency (Fig. 3.3 B; Table 3.1). In contrast, mutation of Asn1791 alone did 
not affect agrins activity at all, although this amino acid also lies at the site where the structures of 
agrin-B/z-8 and agrin B/z-0 isoforms deviate (Stetefeld et al., 2004). In addition, to being more ac-
tive, constructs carrying a mutation in Asn1779 were expressed at considerably lower levels than 
any other construct (see supplementary figure 1 B). This gain in potency might be due to increase 
in flexibility of the B/z loop caused by  the loss of the side chain of Asn, which might as well desta-
bilize the 3-dimentional structure of the LG domain through its carboxyl- or amino-group.
N1779A:  H N A V T K S H L S N E I P A E K A L Q S N H
N1791A:  H N A V T K S H L S N E I P A E K A L Q S N H
H1778A:  H N A V T K S H L S N E I P A E K A L Q S N H
E1785A:  H N A V T K S H L S N E I P A E K A L Q S N H
K1786A:  H N A V T K S H L S N E I P A E K A L Q S N H
N1779A/N1791A: H N A V T K S H L S N E I P A E K A L Q S N H
V1781A:  H N A V T K S H L S N E I P A E K A L Q S N H
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Figure 3.3 | Effects on MuSK phoshorylation of agrin proteins containing mutations within amino 
acids flanking the B/z splice site.
(A) Mutations introduced in C45A4B8 agrin construct immediately before and after the B/z exon. 
(B) Except mutation C45N1779A, which showed a 60-fold increase in potency to an EC50MuSK of 
0.5pM, for no other mutation flanking the B/z region any considerable effect in inducing MuSK 
phosphorylation was observed. 100% was set for maximum phophorylation level of C45A4B8 
agrin. Each data point represents mean +/- SEM of at least 4 replicates.
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3.4.4 Agrin binding to α-dystroglycan is modulated by the pres-
ence of an insert in its A/y and B/z splice sites
It was previously demonstrated that muscle agrin binds to α-DG with a 10-fold higher affin-
ity than neural agrin (Gesemann et al., 1996; Sugiyama et al., 1994). Therefore, we decided to 
measure α-DG binding of all our mutation constructs to see whether the binding to α-DG in-
versely correlates with potency to induce MuSK phosphorylation. In a first approach, the binding 
of agrin to α-DG was analyzed on an overlay transfer assay. Purified α-DG was separated by gel 
electrophoresis, transferred to nitrocellulose and probed with the agrin mutants. Bound agrin was 
subsequently detected with an antibody directed against human γ1. In this assay neither the native 
C45A4B8 neural agrin (Fig 3.4 B) nor recombinant agrin mutated within the B/z-8 insert showed 
a binding to α-DG (not shown), however C45A0B0, C45A4B0 and C45A0B8 agrin bound strongly 
(Fig 3.4 B). Thus, we decided to measure α-DG binding with the more sensitive solid phase bind-
ing assay. Bound agrin was detected with an antibody directed against human γ1, and the signal 
was quantified using an ELISA reader. In agreement with the transfer overlay assay C45A4B8 agrin 
had the same binding affinity as all the mutants (data not shown) and was significantly lower than 
affinity of all other tested agrin constructs (Fig 3.4 B, C, D, and E; Table 3.2). Therefore, mutations 
of amino acids within or surrounding the B/z splice site do not influence the binding to α-DG 
even though some of them showed a significant reduction in potency to activate MuSK, demon-
strating that the binding to α-DG is mediated by other sites within the LG domain.
Surprisingly, C45A0B8 agrin showed a higher binding affinity to α-DG than C45A4B0 agrin 
(Fig. 3.4 E and F; Table 3.2). Concomitantly, with high binding affinity to α-DG, C45A0B8 has a 4-
fold lower EC50
MuSK
 compared to C45A4B8 agrin (Fig. 3.4 A; Table 3.1), indicating that binding to 
α-DG might play an auxiliary role for activation of MuSK. Further, we were asking if dimerization 
of two single LG domains would bind to α-DG. To address this question we generated four con-
structs analogously to the C45-agrin containing the constant region of human γ1 IgG, which force-
dimerizes two proteins. The constructs contained either the 2nd or the 3rd LG domain of agrin, with 
or without exon in the respective splice site. α-DG binding of these constructs was then tested in 
solid phase binding assay. Interestingly, only LG2A0 and LG3B0 lacking the exon in their respec-
tive splice sites bound weakly to α-DG. In contrast LG2A4 and LG3B8 did not bind to α-DG at 
all (data not shown). Based on these results we can conclude that exons within the LG2 or LG3 
domain interfere with α-DG binding-sites of agrin. Moreover, the EC50
MuSK
 of LG3B8 domain 
of agrin is ~4nM (data not shown) which is similar to the EC50 ~13nM previously measured for 
AChR clustering (Gesemann et al., 1995), in contrast LG3B0 and LG2A4/0 did not activate MuSK 
at all.
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Figure 3.4 | Phosphorylation of MuSK is increased in parallel to an increase in binding affinity to α-dystroglycan but alterations in its potency 
do not affect α-dystroglycan binding.
(A) C45A0B8 agrin lacking an insert at its A/y splice site has an increased potency to phosphorylate MuSK compared to C45A4B8. (B) purified a-
dystroglycan was separated on a 7.5% SDS-PAGE, blotted to nitrocelluloce and overlaid either with C45A4B8, C45A0B0, C45A4B0 and C45A0B8 agrin, 
whereas only binding of C45A4B8 agrin is not detectable (C, D, E, F) Analysis of α-dystroglycan binding of the same constructs in a solid phase 
binding assay showed different affinities for the tested constructs demonstrating that KdC45-A0B0 > KdC45-A0B8 > KdC45-A4B8 > KdC45-A4B8. To allow 
comparison of the binding curves for different agrin constructs, data were normalized to the fitted value for absorbance at total saturation. 
Each value represents mean +/- SEM of 3 replicates.
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3.4.5 Agrin’s activity to phosphorylate MuSK is shifted 140-fold 
to lower potency after blocking it’s binding to α-DG
It was shown that α-DG is not the agrin receptor (Meier et al., 1996; Jacobson et al., 1998) and 
that postsynaptic specializations like AChR clustering for instance can also form in absence of α-
DG in cultured myotubes (Jacobson et al., 1998) and in vivo (Cote et al., 1999). Here we provide 
data, where we suggest that α-DG supports agrin in activating MuSK phosphorylation, by captur-
ing agrin at the muscle surface and hence to induce AChR aggregation. To support this hypoth-
esis, the  binding of C45 agrin to α-DG was either blocked with heparin (Gesemann et al., 1996) 
or competed with excess of N25C95A0B0 muscle agrin, which strongly binds to the muscle surface 
having additionally a laminin binding domain. Heparin inhibition of C45A4B8 and C45A0B8 bind-
ing to α-DG shows a 20- and 10-fold shift to lower EC50
MuSK
 respectively (Fig. 3.5 C and D; Table 
3.3). The activity to phosphorylate MuSK of C45A4B8 versus C45A0B8 agrin is stronger inhibited 
by heparin due to the presence of the KSRK motif within the A/y splice site of C45A4B8, which 
was shown to strongly bind heparin (Gesemann et al., 1996). Furthermore, competition of bind-
ing of C45 agrin isoforms to α-DG with 100-fold excess of N25C95A0B0, endures a 140-fold shift 
of the EC50
MuSK
 for C45A4B8 and a ~60-fold shift for C45A0B8 to lower potency (Fig. 5A and B; 
Table 3.3). Interestingly, after inhibition of agrin’s binding to α-DG, the measured EC50
MuSK
 for 
C45A4B8 is very similar to the EC50
MuSK
 measured for LG3B8, a truncated form of agrin, which 
does not bind to α-DG at all. These experiments strengthen the hypothesis that the binding of 
agrin to α-DG is necessary to increase agrin’s MuSK phosphorylating activity. Analogously, it was 
shown that AChR clustering by N25C21B8 agrin (Meier et al., 1998) is strongly increased com-
pared to soluble C21B8 (LG3B8). The higher clustering activity was attributed to the N-terminus, 
which anchors the protein to laminin and hence is more concentrated in the basal lamina com-
pared to the soluble LG3B8-agrin.
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Table 3.2 | exon insert in agrins A/y and/or 
B/z splice site determines α-DG binding
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Figure 3.5 | MuSK phosphorylation can be inhibited with heparin and an excess of muscle agrin.
(A, B) Activation of MuSK was competed with N25C95A0B0 agrin. A shift of MuSK phosphorylation to lower potency is observed for C45A4B8 and 
C45A0B8 agrin (A, B). A similar, but less prominent shift is seen by competition of MuSK activation with heparin (C, D). 100% was set for maximum 
phophorylation level of C45A4B8 agrin. Each data point represents mean +/- SEM of at least 4 replicates.
Table 3.3 | Inhibition of agrin binding to α-dystroglycan results 
in a shift in potency  
 C45-A4B8 590.4 +/- 102
 C45-A0B0 47.4 +/- 6
 C45-A4B0 104.9 +/- 14
 C45-A0B8 69.0 +/- 7
kD [pM]  SEM [pM]
C45-A4B8 32.1 +/- 4.4
C45-A0B8 8.7 +/- 1.1
C45-A4B8 + N25C95-A0B0 4559.0 +/- 2460
C45-A0B8 + N25C95-A0B0 557.4 +/- 93 
C45-A4B8 + Heparin 756.5 +/- 162
C45-A0B8 + Heparin 107.7 +/- 48
EC50 [pM]  SEM [pM] 
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Supplementary Figure 1 | Expression and AChR clustering activity of all recombinant agrin constructs.
(A) Western blot analysis of all agrin proteins expressed from HEK 293-EBNA cells. With exception of mutants C45N1779A and C45N1779A/N1791A that 
show a very poor expression level all other recombinant agrin proteins are expressed at the expected size of 75 kD. (B) AChRs are visualized by 
staining with α-Btx. All recombinant isoforms of agrin that showed MuSK phosphorylation also show AChR clustering activity. C45A4B0 surpris-
ingly showed to cluster AChRs without bearing any MuSK phosphorylation activity.
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3.5 Discussion
The mechanism of mRNA splicing is coming up more frequently in processes where the inter-
action between two proteins is fine tuned in order to increase the ligand-receptor affinity leading 
to specific signaling events during development (reviewed in Graveley, 2001). In keeping with 
this model, also development of the neuromuscular junction underlies such mechanisms, as agrin 
was shown to undergo extensive alternative splicing (reviewed in Bezakova and Ruegg, 2003). 
Agrin’s most potent AChR inducing activity was mapped to the three C-terminal LG-domains 
including an exon of 8 amino acids in length in the B/z splice site (Gesemann et al., 1995), which 
is essential for activating MuSK and to induce AChR clustering. Using the newly developed two-
side phosphorylation ELISA, we now examined the B/z exon and mapped amino acids important 
for inductive events, which lead to phosphorylation of MuSK and additionally determined their 
contribution to the binding of α-DG.
In initial studies, we compared MuSK phosphorylation induced by muscle agrin (C45A0B0, 
C45A4B0), C45A4B8 neural agrin and a mutated form of neural agrin where all eight amino acids 
of the B/z inserts were mutated to alanines, where we could show that the contribution of the 
amino acid side-chains are essential for agrin’s activity. In fact, we measured a 100-fold loss in 
potency for C45B8-8A agrin mutant, which surprisingly still showed a higher activity than muscle 
agrin that was not active at all. Moreover, by introducing single, double and triple mutations 
into the B/z exon we were able to define agrin’s activity to the Asn-Glu-Ile motif, three highly 
conserved amino acids across all species used for comparison. This finding was confirmed by the 
C45HLSNEIPAB8AAANEIAA mutant, where only the NEI triplet was preserved and all other amino 
acids were mutated to alanine, showing almost the same activity as C45A4B8 agrin. 
These findings led to two conclusions about the importance of the inclusion of an exon at 
the B/z splice site. First, the activity of the B/z-8 insert is exclusively given by the tripeptide NEI, 
which is also highly conserved between all species. Second, all other inserted amino acids function 
as a spacer in order to move the side chains of flanking amino acids to a more exposed place in 
the structure of the LG3 domain where they are enabled to additionally influence agrins activity. 
As shown by the crystal structure of LG3 domain of agrin, the accommodation of the B/z-8 exon 
into the LG3-domain does not perturb the overall structure of the LG3 domain but only shifts 6-7 
amino acids in proximity to the B/z insert to a site out of the globular structure of the LG3 domain 
(Stetefeld et al 2004).
Further analysis of amino acids flanking the B/z splice site did not reveal any new indications 
about the contribution of their side chains. The initial hypothesis that the Glu1785 and/or Lys1786 
may contribute to the coordination of Ca2+ (Stetefeld et al., 2004) and therefore also stabilize the 
Chapter 3
82
B/z loop was not confirmed. Interestingly however, mutation of Asp1779 resulted in a 60-fold in-
crease in potency (Table 3.1). One interpretation of this result is that Asp1779 strongly stabilizes 
the structure, and therefore the lack of this side chain has destabilizing effects on the structure, in-
creasing the flexibility of the B/z loop resulting in a higher activity. These observations fit with the 
model proposed by Stetefeld et al (2004), where they suggest that the plasticity of the interaction 
interface optimizes the selectivity through induced fit binding. Furthermore, the low expression 
level of the constructs containing the Asp1779 mutation strengthens this hypothesis.
Next, we attempted to determine the contribution of the B/z splice insert in the binding to 
α-DG, suggesting that agrin mutation with lower potency in activating MuSK may result in in-
crease of the binding to α-DG, as it was shown for muscle and neural agrin that an insert at both 
splice sites decreases about 10-fold the binding affinity to α-DG (Gesemann et al., 1996; Sugiyama 
et al., 1994). This hypothesis could not be verified, as all mutations within and outside the B/z 
splice site had exactly the same α-DG binding affinities as the wild-type C45A4B8 agrin. Moreover, 
binding studies of different muscle and neural agrin isoforms showed that the strongest binding 
agrin isoform lacked both inserts at its A/y and B/z site and the weakest binding agrin isoform 
included an exon at both splice sites. In contrast agrin isoforms lacking either one exon at its 
A/y or B/z splice site did bind stronger than C45A4B8 but weaker than C45A0B0 agrin. Interest-
ingly, the stronger binding of C45A0B8 to α-DG was concomitant with the activity of this agrin 
isoform, which also showed a 4-fold increase of the EC50
MuSK
 compared to C45A4B8 agrin. From 
these results we get two further insights. First, increased binding of agrin to the muscle surface by 
interacting with α-DG leads to a higher activity of agrin and loss in activity by changing amino 
acid residues does not increase the binding to α-DG. Second, the binding to agrin is mediated by 
a domain lying close to the A/y- or B/z-splice sites and that the insert significantly disturbs the 
interaction of agrin to α-DG. Furthermore, this hypothesis is supported by experiments showing 
that dimerization either of LG2 or LG3 including an exon do not bind to α-DG whereas the same 
domains lacking an insert show weak binding. Based on these findings we propose a model for 
the binding of agrin to α-DG, suggesting that the binding interface of agrin to α-DG needs the 
exposure of two LG domains, whereas the interacting sites are in close vicinity to the splice inserts 
A/y and B/z, as an insert in these sites can disturb the binding (Fig. 3.6). 
In a next series of experiments we analyzed whether the binding of agrin to α-DG per se is 
implicated in agrins activity. Inhibition of agrin to bind to α-DG by heparin or by competing with 
N25C95A0B0 agrin showed a 100- and 150-fold decrease in potency for C45A0B8 and C45A4B8 
respectively. In contrast, further experiments showed that MuSK phosphorylation by the single 
LG3B8 domain could not be inhibited neither by heparin nor by muscle agrin. Interestingly, 
EC50
MuSK
 for C45A4B8 where the binding to α-DG was inhibited showed the same potency as the 
B/z exon of agrin modulates MuSK phosphorylation and α-dystroglycan binding 
83
EC50MuSK measured for LG3B8, which does not bind to α-DG at all. According to these results 
agrin needs to bind to the muscle surface in order to efficiently activate MuSK phosphorylation. 
Analogously, it was reported that the LG3B8 domain is much more efficient in inducing post-
synaptic specializations, if provided with the N-terminal domain, which confers its binding to 
laminin (Meier et al., 1998). Therefore, we can conclude that α-DG is used as an auxiliary factor 
in order to capture agrin to the muscle surface, enabling agrin to act in much lower doses. 
In summary, our data provide strong evidence that activity of agrin resides mostly in the NEI 
tripeptide motif within the B/z splice site and is additionally supported by amino acids immedi-
ately flanking the B/z insert. Further, our data also show that α-DG may impinge on agrins activ-
ity by concentrating the molecule at the muscle surface where it is needed to induce postsynaptic 
differentiation by interacting with its still unknown receptor. This further characterization of the 
active domain of agrin combined with structural information of agrin might be a useful tool to 
identify the receptor for agrin by computational analysis. In this aspect, the binding of nidogen 
to laminin, which is mediated by a similar motif DPNAV might be a model to consider (Pöschl et 
al., 1996).
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Figure 3.6 | Tandem model of LG2A4-EGF-LG3B8.
The backbone of both LG-domains is drawn in steelblue and the EGF domain in green. 
Splice inserts at the A- and B-site are shown in red and blue, respectively. A surface pres-
entation is underlined semi-transparent.
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4.1 The right approach to find the agrin receptor 
During embryonic development motor axons induce the formation of the motor endplate, a 
small region of the myotube membrane rich in AChRs. The heparan sulfate proteoglycan agrin, 
which is secreted by the growing axon, is the key organizer of postsynaptic specializations such as 
clustering of AChRs (McMahan, 1990). The release of agrin by the nerve leads to rapid activation 
of MuSK to mediate AChR clustering (Glass et al., 1996). It is now clear that MuSK is the signal-
ing component activated by neural agrin. However, MuSK does not bind directly to neural agrin 
indicating that activation of MuSK depends on a muscle-specific co-receptor (Glass et al., 1996). 
Even though a number of key players involved in NMJ development are known, neither the mode 
of how agrin activates MuSK nor of how MuSK activates downstream signaling, which leads to 
AChR clusters is known.
The search for the agrin co-receptor has remained elusive so far. Many research groups, includ-
ing our lab, have invested big effort using a variety of techniques to identify the agrin binding pro-
tein, but traditional methods that were applied successfully in other cases failed. The possibility 
that the co-receptor might be a membrane-associated protein could cause decisive difficulties in 
interaction studies because of its hydrophobic nature, therefore the choice of the appropriate ap-
proach has to be well considered. We chose the yeast-based membrane associated split-ubiquitin 
system to seek for the agrin receptor (Stagljar et al., 1998). Based on the powerful technique as 
the YTH system (Fields et al., 1989), this novel method was adapted to search for proteins that 
encompass the membrane or are linked to it. The advantage of the mYTH system is that not only 
membrane-associated proteins that interact with MuSK can be obtained but also intracellular 
MuSK-interactors. Another general advantage in yeast-based approaches is that the interaction is 
taking place in vivo, that the organism is easy to handle and allows the screening of a large number 
of proteins compared to mammalian cell based systems, like fluorescence or bioluminescence en-
ergy transfer system (FRET, BRET; reviewed in Boute et al., 2002). In contrast, the big disadvan-
tage of yeast is that mammalian proteins might miss important posttranslational modifications or 
might be mis-targeted in the cell. Nevertheless the mYTH was the system with the most promising 
success rate.
Since MuSK is believed to be associated with the co-receptor, it was used as bait in the mYTH 
screen. Moreover, in order to have all components of the receptor complex present in the yeast 
cell, and thus to ensure a possible interaction between MuSK and the candidate co-receptor, we 
further modified the mYTH to express also the ligand to result in a ‘three hybrid system’. There-
fore, the yeast reporter strain was constructed in a way that additionally to MuSK it expresses also 
the most C-terminal LG3B8 fragment of agrin, which is the smallest still active form of agrin that 
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can induce MuSK phosphorylation and AChR clustering (Gesemann et al., 1996; Cornish et al., 
1999).
Taking together, after a promising start we ended up with thousands of candidates that could 
never be confirmed. The failure of the project was probably due to technical limitations of this 
novel system and not because of the biological nature of the interaction between the co-receptor, 
agrin and MuSK. 
The failure to seek the identity of the agrin co-receptor up to now, indicates that the co-recep-
tor necessary for agrin-MuSK signaling is either ‘just’ a not identified modification of MuSK, 
which might confirm technical limitations of available systems, or might be a receptor of high-
er order comprising more than one additional component like it was shown for e.g. the ciliary 
neurotrophic factor (CNTF) receptor that was found to be a ternary complex formed by the mem-
brane-anchored CNTF receptor and two receptor tyrosine kinases gp 130 and LIFRß (Davis et al., 
1993; Stahl and Yancopoulos, 1994). Beside this hypothesis, there are additional possibilities that 
could underlie agrin signaling. These are: (i) a transmembrane or a membrane anchored protein 
that binds agrin as bona fide agrin receptor, (ii) a soluble co-ligand that acts with agrin to activate 
MuSK, (iii) a post-translational modification or (iv) alternative mRNA splicing of MuSK that al-
lows agrin to bind directly to MuSK. In five out of the six listed possibilities also the mYTH would 
have failed.
As it was previously shown that dimerization of MuSK can lead to a fully developed postsynap-
tic apparatus in vivo (Hopf and Hoch, 1998; Jones et al., 1999), the presence of another kinase like 
in the complex mechanism of CNTF signaling is none likely. Moreover, since biochemical and ge-
netic methods failed to find a co-receptor, a fascinating idea would be if MuSK itself would be the 
agrin receptor where its specificity is acquired by posttranslational modifications or by alternative 
mRNA splicing. Models where posttranslational modifications, such as glycosylations, can serve 
as cofactors to recruit ligands to their cognate receptors to ensure efficient interactions is becom-
ing more and more considered (Bernfield et al., 1999; Perrimon and Bernfield, 2000). Especially, 
the importance of differential sulfations and epimerization of polysaccharide chains, which leads 
to the more complex heparan sulfate proteoglycans (HSPG), has been well illustrated in animal 
model systems, which demonstrated that genetic removal of enzymes involved in heparan sulfate 
(HS) polymerization reactions causes severe and early developmental patterning defects of a va-
riety of signaling pathways (Bülow and Hobert, 2004; Herman and Horvitz, 1999; Inatani et al., 
2003; Morio et al., 2003; Perrimon and Bernfield et al., 2000). Moreover, recent studies showed 
that overexpression of the glycosyltransferase LARGE can restore the binding of α-dystroglycan 
to laminin in cells derived from patients suffering from congenital muscular dystrophy, where 
mutations in glycosyltransferases have been found to be responsible for the disease (Grewal and 
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Hewitt, 2002; Barresi et al., 2004; Kanagawa et al., 2004).
Even though it was shown that certain glycosyltransferases are expressed selectively at synaptic 
sites in skeletal muscle (Scott et al., 1990), resulting in concentration of certain carbohydrate epit-
opes attached to proteins at neuromuscular synapses (Scott et al., 1988), glycosylation has not been 
considered in agrin-MuSK interaction. Up to now, there is just one report where glycosylation 
sites in MuSK were analyzed but without any significant result (Watty and Burden, 2002).
Closer analysis of putative glycosylation sites in MuSK showed that MuSK contains five puta-
tive glycosylation sites (Fig 1.4) and not three as reported by Watty and Burden (2002). Interest-
ingly, these two additional glycosylation sites reside in only an alternatively spliced exon encoding 
10 amino acids. This finally raises an additional hypothesis where MuSK-specificity can be addi-
tionally modulated by alternative mRNA splicing as it is known for agrin. 
4.2 Amino acids within and outside the B/z splice site 
contribute to agrin’s inductive activity, which lead to 
MuSK phosphorylation 
McMahan formulated the ‘agrin hypothesis’ in 1990 postulating that agrin, which is released 
from the motor-nerve terminal, binds to a receptor on the muscle-cell surface inducing postsyn-
aptic differentiation. Depending on the time point and the tissue where agrin is expressed, differ-
ent exons are combined by alternative splicing to result in agrin proteins with different character-
istics. While the amino-terminal domain of agrin is responsible for anchoring the protein to the 
membrane or its binding to laminin (Denzer at al., 1995, 1997; Mascarenhas et al., 2003; Neumann 
et al., 2001; Burgess et al., 2000) the carboxy-terminus is responsible for binding to α-dystroglycan 
and to the agrin receptor. Whereas for the binding to α-dystroglycan, the first two LG domains 
are needed, the binding to the receptor is confined to the last LG domain (Gesemann et al. 1996; 
Hopf and Hoch, 1996). It was also shown that only agrin isoforms containing an insert at its B/z 
splice site are capable of inducing AChR clustering and phosphorylation of MuSK, whereas the 
isoform containing the shortest exon of 8 amino acids is the most active one (Gesemann et al., 
1995). In our work we aimed at identifying single amino acids responsible for agrin’s capability 
to activate MuSK for two reasons. First, the identification of a precise map of the ‘active’ amino 
acid side-chains could give new insights in the mechanism of action of agrin with its non-identi-
fied co-receptor. Further, together with 3-dimensional structure of the LG3-domain of agrin and 
today’s protein databases one could aim to identify the agrin co-receptor based on computational 
models. Second, the exact mapping of the amino acids responsible for MuSK activation could give 
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the fundaments for designing new drugs by ‘peptido mimetica’ that are able to activate the MuSK 
pathway, which would lead to the stabilization of the NMJ’s and therefore to a delay of dystrophic 
symptoms in e.g. hospitalized patients.
In summary, we identified the NEI tripeptide motif within the B/z-8 splice variant, which pro-
vide the side-chains mainly responsible for agrins capability to induce MuSK phosporylation. In 
spite of this, the NEI motif is not totally responsible for agrins activity. In fact, our results show 
that also amino acids flanking the B/z insert critically contribute to agrins activity. However, in-
vestigation of amino acids adjacent to the B/z insert did not give any additional information about 
involvement of some other important side-chains. Nevertheless, we could not completely fulfill 
our goals by mutational analysis, we gained on the other hand some new insights in the role of 
α-DG in activation of MuSK phosphorylation and consequently in the induction of the formation 
of the postsynapse. Furthermore, we also demonstrate that α-DG plays a crucial role in activation 
of MuSK. Here we present a new model, where α-DG as the main binding protein of agrin on the 
muscle surface, plays an auxiliary role in capturing agrin at the muscle surface and presenting the 
molecule to the receptor complex in order to efficiently activate MuSK. Moreover, our observa-
tions lead also to the hypothesis that AChR receptor clustering can be segregated in two different 
pathways, one that is driven through MuSK and the other through α-DG, as it was previously 
described for laminin (Sugiyama et al., 1997; Montanaro et al., 1998; Burkin et al., 2000; Marangi 
et al., 2002).
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